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ABSTRACT
This study investigated the involvement of oxygen free radicals 
in reperfusion arrhythmogenesis using the isolated rat heart. By 
studying the movement of potassium using the radioactive tracer ion 
86Rb+, it was shown that both reperfusion and free radical 
generation brought about a substantial efflux of 86Rb+. This 
response was potentially arrhythrnogenic and occurred at a time when 
reperfusion arrhythmias were observed.
Whilst the free radical scavenger glutathione was shown to be
anti-arrhythmic and to attenuate the reperfusion-induced efflux of 
86Rb+, several other anti-free radical interventions proved 
ineffective. The importance of oxygen free radicals to reperfusion 
arrhythmogenesis is therefore questionable. Furthermore, 
glutathione exhibited a pronounced coronary dilator action, 
although by comparing the effects of other sulphydryl agents and 
vasodilator drugs with those of glutathione, it was shown that 
coronary dilation did not significantly contribute to the drug's 
antiarrhythmic action. A reduction of 86Rb+ efflux following 
reperfusion appeared to be more closely associated with 
drug-induced coronary dilation than with a reduction of 
arrhythmias.
A possible source of oxygen free radicals in the heart is the 
enzyme xanthine oxidase. The present study demonstrated that the 
xanthine oxidase inhibitor allopurinol is antiarrhythmic but not 
through inhibition of xanthine oxidase, since its active metabolite 
oxypurinol was without effect on the incidence of reperfusion 
arrhythmias. The location and activity of xanthine oxidase were 
investigated in cell cultures using luminol-enhanced
chemiluminescence. In rat cells, xanthine oxidase exists 
predominantly in the vasculature, thus precluding a role for the 
enzyme in reperf us ion-induced damage since the half-lives of 
radicals are probably too short to allow diffusion from the 
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11.1 REPERFUSION-INDUCED ARRHYTHMIAS:DEFINITION AND CLINICAL 
RELEVANCE
Approximately 50% of deaths that occur in the western world in 
people over the age of 20 years are the direct result of 
cardiovascular disease (Pantridge et al,1975). In the majority of 
cases, death is sudden and unexpected, and whilst ventricular 
arrhythmias resulting from myocardial ischaemia are thought by some 
to be the underlying cause (Corr and Witkowski, 1984 ; Luchessi,
1984), post-mortem examinations often fail to show evidence of 
coronary occlusion (Sheridan, 1987). Observations that link 
transient changes in coronary artery tone to the development of 
arrhythmias have directed a considerable amount of research into 
the phenomenon of reperfusion-induced arrhythmogenesis (Manning and 
Hearse, 1984). Reperfusion-induced arrhythmias, as defined by 
Manning and Hearse (1984), are disturbances of heart rhythm that 
arise as a consequence of the total or partial restoration of 
coronary flow to a previously ischaemic region of heart tissue. The 
clinical relevance of reperfusion arrhythmias is immediately 
apparent given the increasing use of thrombolytic therapy and 
mechanical coronary angioplasty. The success of such techniques is 
often assessed by the development of arrhythmias (Goldberg et al, 
1983). Whilst the involvement of reperfusion arrhythmias to sudden 
cardiac death is difficult to substantiate, the possibility remains 
that it is an important contributory factor.
21.2 FACTORS THAT INFLUENCE THE DEVELOPMENT OF REPERFUSION 
ARRHYTHMIAS
1.2.1 Ischaemic Duration
Several studies have demonstrated an inverse relationship between 
the incidence of reperfusion-induced arrhythmias and the duration 
of the preceeding period of ischaemia (Balke et al, 1981; Penny and 
Sheridan, 1983; Creme et al, 1983). The vulnerability of isolated 
rat hearts to ventricular fibrillation (VF) exhibits a bell-shaped 
relationship with ischaemic duration (Manning and Hearse, 1984).
The highest incidence of VF occurs during reperfusion of hearts 
rendered ischaemic for 15 min. A similar relationship was 
demonstrated in the anaesthetised rat, with the exception that the 
bell-shaped curve was displaced to the left, showing a maximum 
vulnerability to reperfusion arrhythmias after only 5 min of 
ischaemia. Evidence exists for such a relationship in humans and 
has been reviewed by Corr and Witkowski (1983).
Findings such as these suggest that the development of 
arrhythmogenic conditions during myocardial ischaemia is 
time-dependent. Ischaemia-induced changes that may contribute to 
the development of arrhythmias are considered later in more detail.
1.2.2 The Rate of Reperfusion
Investigations of the relationship between reperfusion rate and the 
development of reperfusion arrhythmias have yielded equivocal
3results. Petropoulos and Meijne (1964) were able to reduce the 
incidence of VF by reperfusing globally ischaemic isolated guinea 
pig hearts with low flow rates. In the same heart model, Sheridan 
(1987) was unable to reproduce these results, but demonstrated a 
delayed onset of VF with gradual reperfusion. In an isolated rat 
heart model of regional ischaemia, Zakaria (1985) reduced the 
incidence of reperfusion arrhythmias by lowering the rate of 
reperfusion. Speculative explanations for these effects (Corr and 
Witkowski, 1983; Manning and Hearse, 1984) include the facilitation 
of a slower, more uniform washout of toxic metabolites formed 
during ischaemia, and a less abrupt reoxygenation process resulting 
in a more gradual restoration of ionic homeostasis.
The general concensus of opinion is that rapid changes of the 
substrate and ionic environment across the reperfused region may 
contribute to the development of reperfusion arrhythmias (Corr and 
Witkowski, 1983).
1.2.3 Collateral Flow
Variations between species in the degree of existing collateral 
circulation, and the ability to develop a collateral supply under 
ischaemic conditions, may affect the vulnerability of hearts to 
reperfusion arrhythmias. The degree of recovery afforded by 
reperfusion, in terms of cardiac performance and electrophysiology, 
is improved when myocardial necrosis is limited, which is itself 
achieved when collateral flow is high (Przyklenk et al, 1986). 
However, reperfusion-induced recovery may also be arrhythmogenic,
4as will be considered later (section 1.3.2).
For experimental models of myocardial ischaemia/reperfusion, the 
choice of species is critical. The hearts of some animals possess a 
high degree of collateral flow and in the guinea pig, for example, 
it is impossible to induce regional ischaemia because of this 
(Schaper, 1984).
1.3 PUTATIVE MECHANISMS OF REPERFUSION ARRHYTHMOGENESIS
1.3.1 Electrophysiological Changes Associated with Ischaemia and 
Reperfusion
During myocardial ischaemia, the electrophysiological changes that 
occur in ischaemic tissue are non-uniform. Progressive reductions 
of action potential duration, resting membrane potential and the 
maximum rate of depolarisation (V»ax) occur throughout the 
ischaemic region but at different times (Downar et al, 1977). The 
heterogeneity of depolarisation is further demonstrated by a 
fractionation of electrical activity into multiple, widening 
spikes. Endocardial to epicardial electrical conduction is delayed 
(Murdock et al, 1980) and the effective refractory period within 
the ischaemic zone has been shown to both shorten and lengthen 
(Russell and Oliver, 1978), again indicating inhomogeneity of 
electrical activity. Some studies (Downar et al, 1977; Russell et 
al, 1977) have demonstrated the development of post-repolarisation 
refractoriness.
5Some ischaemia-induced changes in action potential characteristics 
are normalised upon reperfusion. Rapid recovery of the amplitude 
and upstroke velocity is achieved within seconds of reperfusion, 
particularly when the ischaemic period is short (Penny and 
Sheridan, 1983). Other indices of electrical activity take longer 
to recover. Re-synchronisation of depolarisation is only achieved 
after several minutes of reperfusion (Kaplinsky et al, 1981), and 
the effective refractory period is reduced below ischaemic values 
(Naimi et al, 1977) and so increases the heterogeneity of 
refractoriness between normal and previously ischaemic tissue.
The heterogeneity of electrical activity during ischaemia therefore 
appears to be exacerbated by reperfusion. The restoration of 
coronary flow to an ischaemic region paradoxically results in the 
genesis of ventricular arrhythmias through changes in action 
potential characteristics and electrical conduction. The 
contribution of these changes to possible arrhythmogenic mechanisms 
is discussed below.
1.3.2 Arrhythmias Resulting from Re-entry Mechanisms
Circus movement re-entry results from the unidirectional block of 
impulse conduction, which allows retrograde re-excitation of tissue 
proximal to the area of block (Rosen et al, 1987). To allow the 
proximal tissue to redover excitability following the initial 
impulse, there must also be a slower tissue conduction velocity 
and/or shortened refractoriness before re-entry can occur, both of
6which are observed during early reperfusion, when VF is generated 
(Corr and Witkowski, 1983).
It is WDrthy of note that re-entry does not necessarily lead to VF 
(Sheridan, 1987). Dysrhythmias resulting from this mechanism may be 
organised to activate the whole ventricular mass, appearing as VT. 
Only when the electrophysiology of cardiac tissue is sufficiently 
disturbed (for example, when an activation wavefront interrupts an 
incompletely depolarised area of tissue) is synchronous activity 
lost, leading to fibrillation. This situation is more likely to 
occur with an increasing heterogeneity of electrophysiological 
conditions, such as those brought about by ischaemia, upon 
reperfusion and during reperfusion-induced recovery of the action 
potential. According to Manning and Hearse (1984), the 
heterogeneity of recovery may be particularly relevant to re-entry 
mechanisms following reperfusion. The authors suggest that the 
heterogeneity of the developing injury is crucial to the 
development of ischaemic arrhythmias, whereas reperfusion 
arrhythmias may also be a consequence of the heterogeneity of 
cellular recovery processes. Evidence in support of this hypothesis 
is mainly circumstantial. As mentioned earlier, the highest 
incidence of reperfusion-induced VF was shown to occur in the 
isolated rat heart after 15 min of ischaemia (Crome et al, 1983). 
With longer ischaemic durations, the incidence of VF declines. It 
has been suggested (Hearse, 1983) that reversible cellular injury 
occurs with early reperfusion of ischaemic tissue and that 
reversibility of damage lends itself to re-entry mechanisms. Early 
reperfusion (i.e. reperfusion following short (10-15 min) periods
7of ischaemia) in isolated rat hearts predisposes to the development 
of VF (Lubbe et al, 1978; Woodward and Zakaria, 1983; Manning and 
Hearse, 1984).
It therefore appears likely that life-threatening reperfusion 
arrhythmias (VF) are brought about predominantly by re-entry 
processes. This argument is supported by several authors (Corr and 
Witkowski, 1983; Manning and Hearse, 1984; Sheridan, 1987), 
although the initiation of reperfusion arrhythmias by re-entry 
mechanisms remains a matter of controversy (Sheridan, 1987).
1.3.3 Enhanced Automaticity
Cardiac autcmaticity is the ability of hearts to initiate action 
potentials as a result of spontaneous phase 4 depolarisation. This 
automatic activity predominates in the sinoatrial node and results 
from the diminution of an outward repolarisation current (carried 
mainly by potassium ions) simultaneous with the initiation of an 
inward current (carried by sodium and calcium ions). The 
intracellular accumulation of a positive charge depolarises the 
cell to a threshold potential and an electrical impulse ensues.
Epicardial mapping experiments in dogs (Ideker et al, 1981) have 
shown that reperfusion-induced VF is initiated shortly after 
synchronous electrical activation of tissue within the border of 
the ischaemic/non-ischaemic zone. It is possible that VF in these 
experiments is caused by rapid autcmaticity, although the precise 
activation sequence was not assessed owing to the small number of
8recording sites confined to the epicardium only. An attempt to 
overcome this problem was recently described by Pogwizd and Corr 
(1987). Using a three-dimensional computerised mapping system to 
simultaneously record from 232 intramural sites in the cat heart in 
vivo, the authors observed VT arising from the subendocardial 
border zone. In 75% of cases, tachycardia was accompanied by 
non-continuous activation of impulses that were uninterrupted, 
suggesting the participation of nonre-entrant mechanisms. 
Tachycardia in the remaining 25% was thought to involve intramural 
re-entry in the subendocardium. Transition of VT to VF, and the 
maintenance of arrhythmias during reperfusion, were associated with 
both nonre-entry and intramural re-entry processes. The transition 
period was associated with rapid acceleration of tachycardia 
through nonre-entrant mechanisms, causing conduction delay and so 
precipitating re-entrant cicuits. No definitive conlusions were 
drawn as to the nature of the nonre-entrant processes, although 
Pogwizd and Corr suggested the involvement of abnormal automaticity 
or triggered activity (see below).
Further evidence for the role of enhanced automaticity in 
reperfusion arrhythmias comes from the work of Sheridan and 
colleagues (1980). Increases in idioventricular rate during 
reperfusion were observed in cats at a time when ventricular 
tachyarrhythmias were most intense. Accelerated idioventricular 
rates have also been observed in humans following intracoronary 
thrombolysis (Goldberg et al, 1983). Sheridan's group attributed 
the rise in rate to stimulation of alpha-adrenoceptors by 
catecholamines released during reperfusion, since depletion of
9myocardial catecholamines countered the rate increase, whereas 
administration of methoxamine (an alpha-receptor agonist) reversed 
the electrophysiological effects of catecholamine depletion 
(Sheridan et al, 1980). An increase in alpha-receptor number during 
ischaemia, proposed by Corr et al (1981), may also contribute to 
the electrophysiological changes observed on reperfusion.
Alternative mechanisms for the generation of tachyarrhythmias are 
early and late afterdepolarisations. Every action potential is 
proceeded by oscillations of membrane potential (Rosen et al,
1987). These afterdepolarisations may occur before completion of 
phase 3 repolarisation (resulting from either or both a decrease in 
the outward repolarising potassium current and an increase in the 
inward current carried by sodium or calcium), when they are termed 
"early" afterdepolarisations. Alternatively, "delayed" 
afterdepolarisations may be observed as oscillations of membrane 
potential occurring on completion of repolarisation following an 
action potential. Delayed afterdepolarisations are seen following 
digitalis toxicity (Rosen et al, 1973). Inhibition of 
sodium-potassium ATPase by the cardiac glycoside leads to an 
increase in the inward sodium current and subsequent calcium 
overload through sodium-calcium exchange (Kass et al, 1978). The 
release of calcium from sarcoplasmic reticulum and mitochondria was 
also demonstrated. Enhanced calcium influx triggers an inward 
current, carried mainly by sodium ions, which results in 
depolarisation (Rosen et al, 1987).
Both early and delayed after-depolarisations may reach threshold
10
potential and initiate tachyarrhythmias. Both rely on the 
intracellular accumulation of calcium ions which may lead to a rise 
in the extracellular potassium concentration. Calcium overload has 
been observed following reperfusion (Hearse, 1977; Ferrari et al, 
1986) and is a possible trigger for the generation of 
afterdepolarisations, although little evidence is available which 
correlates the time of calcium overload with the time at which 
reperfusion arrhythmias occur (Manning and Hearse, 1984). 
Extracellular potassium accumulation does occur during ischaemia 
(Hirche et al, 1980), but no conclusive relationship has been 
demonstrated between extracellular potassium concentration and 
reperfusion arrhythmogenesis.
Although definitive data still need to be produced which link 
reperfusion arrhythmias with enhanced automaticity, the possibility 
remains that the latter initiates arrhythmias. The literature 
reviewed above tends to support the concept that VF following 
reperfusion is initiated by automatic mechanisms and sustained by 
re-entry processes or by a combination of re-entry and nonre-entry 
mechanisms.
1.4 REPERFUSION-INDUCED PERTURBATIONS OF IONIC HOMEOSTASIS
The generation and propagation of ventricular arrhythmias is 
ultimately the result of electrical abnormalities caused by 
disturbances of normal ionic movements. Normal cardiac function, 
and in particular the cardiac action potential, is regulated by 
several ionic species. The following paragraphs briefly consider
11
the ischaemia and reperfusion-induced changes in the homeostasis of 
two such ions; calcium and potassium.
1.4.1 Calcium
The depolarisation phase of the ventricular action potential is 
mediated, in part, by a slow inward current carried by calcium and 
(to a lesser extent) sodium ions (Msrad and Tung, 1982). This 
current, together with an efflux of potassium ions (see below), is 
also responsible for the maintenance of the plateau phase, and in 
this way determines the duration of the action potential. The 
critical involvement of calcium in the determination of action 
potential characteristics, coupled with observations of substantial 
reperfusion-induced calcium overload (Hearse, 1977; Ferrari et al, 
1986), favour the proposal that reperfusion arrhythmias are 
inextricably linked with altered calcium ion fluxes. Delayed 
afterdepolarisations may be precipitated by a high intracellular 
calcium concentration, and this mechanism has been suggested as a 
possible cause of reperfusion arrhythmias (Corr and Witkowski,
1983). In support of this, an increase in extracellular calcium 
concentration (which elevates the intracellular calcium 
concentration) causes a shortening of the action potential plateau, 
an increased rate of phase 0 depolarisation and a prolongation of 
atrioventricular conduction (Gettes, 1981). The slow conduction of 
action potentials arising from these changes would favour circus 
movements of excitation and may lead to re-entry arrhythmias 
(Parratt, 1982).
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Despite these convincing hypotheses, there is little evidence of a 
role for calcium overload in reperfusion arrhythmogenesis. Many of 
the proposed mechanisms fall short by virtue of the timing of 
calcium overload in relation to the timing of VF. The use of 
calcium entry blocking drugs, such as verapamil, has been shown to 
both reduce reperfusion arrhythmias (Bergey et al, 1984) and have 
little effect on arrhythmia incidence (Kane et al, 1984). As yet, 
there is no definitive proof that calcium overload is a trigger for 
VF resulting from the early stages of reperfusion (for reviews, see 
Manning and Hearse, 1984 and Opie and Coetzee, 1987).
1.4.2 Potassium
Potassium, the most abundant intracellular cation, is important for 
the maintenance of the cardiac cell resting membrane potential. At 
rest, the negative potential of the intracellular compartment is 
achieved mainly by virtue of the movement of potassium out of the 
cell along its concentration gradient. This is facilitated by a 
high membrane permeability to potassium ions. The potassium 
gradient is maintained by an inwardly rectifying, voltage-dependent 
potassium channel and the electrogenic sodium-potassium pump (Morad 
and Tung, 1982). During the plateau (phase 2) of non-nodal tissue 
action potentials, there is a large efflux of potassium, the 
magnitude of which depends upon the intracellular calcium 
concentration. There is however, no net change in membrane 
potential because of inward rectification (which effectively 
reduces membrane potassium conductance) and a positive inward 
current carried by calcium and sodium ions. Finally, repolarisation
13
of the membrane is achieved when potassium conductance rises 
simultaneous with a reduction of the inward movements of calcium 
and sodium.
Many studies have been concerned with the changes in extracellular 
potassium ion concentration during ischaemia, with very little 
emphasis on changes associated with reperfusion. During ischaemia, 
potassium accumulates in the extracellular space of the ischaemic 
region and exhibits a triphasic time course (Hill and Gettes, 1980; 
Hirche et al, 1980; Weiss and Shine, 1982). Within 5 to 10 min of 
coronary occlusion, concentrations rapidly rise to between lOmM and 
12mM. Levels plateau for approximately 15 min and then begin to 
rise slowly until the potassium concentration may exceed 30mM. Hill 
and Gettes (1980) have shown that the first two phases are rapidly 
reversed by reperfusion, but the changes in the final, slowly 
rising phase are not reversible and may correspond to the time at 
which irreversible cell damage occurs.
Ischaemia-induced reductions of the resting potential and rate of 
rise of phase 0 and the increase in post-repolarisation 
refractoriness have been attributed to the above changes in 
potassium concentration (Gettes, 1987). Similarly, the initial 
enhancement of excitability and conduction during ischaemia are 
thought to be a consequence of extracellular potassium 
accumulation. Each of these responses can be reproduced by raising 
the potassium concentration of bathing or perfusing solutions 
(Gettes, 1987) and are associated with the complications resulting 
from hyperkalaemia, which may lead to cardiac dysrhythmias
14
(Schwartz, 1978).
Other ischaemia-induced changes could exacerbate the 
electrophysiological changes associated with potassium 
accumulation. Gaspardone and colleagues (1986) postulated an 
ionic-dependent loss of potassium from the myocardium during 
ischaemia, since hypoxic perfusion of rabbit septa induces an 
efflux of (undefined) anions resulting in an electrochemical 
gradient along which potassium ions are extruded. The intracellular 
acidosis associated with ischaemia (Hirche et al, 1980), when 
induced in isolated rabbit hearts perfused with hyperkalaemic 
solutions (Weiss and Shine, 1981), quantitatively reproduced 
ischaemia-induced alterations to action potential duration and 
conduction time (Gaspardone et al, 1986).
A5 previously mentioned, changes in the extracellular potassium 
concentration during reperfusion have received little attention.
The above review illustrates the importance of potassium in 
maintaining the normal action potential in cardiac non-nodal cells 
and the possible role of abnormal potassium fluxes in precipitating 
the aberrant electrophysiological characteristics of ischaemia. It 
is conceivable that alterations of extracellular potassium 
concentrations during reperfusion, and the likely ionic 
heterogeneity caused by such changes, predisposes hearts to 
reperfusion-induced arrhythmogenesis.
15
1.5 BIOCHEMICAL AND METABOLIC FACTORS IMPLICATED IN 
ARRHYTHMDGENESIS
The following is a brief account of biochemical factors which may 
participate in the genesis of ischaemic and reperfusion 
arrhythmias. It is not the purpose of this thesis to provide an 
extensive review of each research area. The information given below 
is therefore intended to be an illustration of the wide-ranging 
complexity of putative endogenous arrhythmogenic agents and 
hopefully provides a source of reference to more detailed 
appraisals.
1.5.1 Prostanoids
The release of products of the oxidation of arachidonic acid has 
been demonstrated during myocardial ischaemia (Coker et al, 1981). 
The balance between the local generation of thromboxne A2 and 
prostacyclin from platelets, leucocytes and the blood vessel wall 
has been implicated as a major contributory factor in ischaemia and 
reperfusion arrhythmogenesis (Parratt, 1987). In patients with 
acute myocardial infarction, plasma levels of thromboxane A2 and 
6-keto PGFialpha (the major metabolite of prostacyclin) were 
elevated and reduced respectively (Friedrich et al, 1985). 
Inhibition of thromboxane synthesis with steroids and non-steroidal 
anti-inflammatory drugs by Karmazyn (1985), reduced the release of 
creatine phosphokinase and LDH associated with reperfusion damage. 
Similar studies by Parratt and Coker (1985) demonstrated a 
protective effect against arrhythmias by inhibition of thromboxane
16
release or by thromboxane receptor blockade, and by an enhancement 
of prostacyclin generation.
The mechanism by which certain prostanoids upset normal cardiac 
electrophysiology is not known. Direct actions on the vasculature 
and platelets are likely to be involved. Prostaglandins of the E 
series, and prostacyclin itself, have been shown to inhibit the 
release of noradrenaline from adrenergic nerve terminals by 
restricting the neuronal uptake of calcium (Hedgvist,1976; Lanier 
and Malik, 1985), and so may protect against ischaemia-induced 
noradrenaline overflow (see section 1.5.3). The possible role of 
prostanoids in free radical-mediated cardiac damage will be 
discussed later (section 1.6).
1.5.2 Free Fatty Acids and Lysophospholipids
Ischaemia associated with reduced coronary flow and reduced oxygen 
supply inhibits the beta-oxidation of free fatty acids (FFA) in the 
mitochondria of ischaemic cells (Neely and Feuvray, 1981). As a 
result, beta-oxidation substrates (long chain acyl coenzyme A and 
long chain acyl carnitine) accumulate, particularly if levels of 
circulating FFA are high. Acyl coenzyme A and acyl carnitine exert 
a detergent action on membranes which may account for their 
inhibitory effects on membrane-bound enzymes such as calcium-ATPase 
(Pitts et al, 1978; Corr et al, 1984) and sodium-potassium ATPase
17
(Owens et al, 1982).
FFA are stored in the myocyte by incorporation into phospholipids 
(Corr et al, 1984). Enhanced activity of membrane-bound or 
lysosomal phospholipases, calcium-dependent enzymes responsible for 
the catabolism of phospholipids, has been proposed to account for 
elevated levels of phospholipids during ischaemia (van der Vusse et 
al, 1982). Mere experimental evidence favours the reduced 
catabolism of lysophospholipids by membrane-bound 
lysophospholipases, the activities of which are reduced under 
ischaemic conditions (Gross and Sobel, 1982) and inhibited by long 
chain acyl coenzyme A, long chain acyl carnitine and FFA (Gross and 
Sobel, 1983). Lysophospholipids are amphiphilic molecules capable 
of insertion into cell membranes, wherein normal membrane function 
may be compromised (Corr and Sobel, 1983). Electrophysiological 
derangements, similar to those seen during ischaemia, have been 
produced in isolated canine Purkinje fibres by the application of 
lysophospholipids (Corr et al, 1979). VF resulting from 
intracoronary infusion of lysophosphatidylcholine has been 
demonstrated in the anaesthetised cat (Bentham, 1986).
The role of the above changes during coronary reperfusion is less 
apparent. Reperfusion-induced calcium overload could enhance 
endogenous phospholipase activity, but the onset of these events 
voild occur at a time associated with irreversible cell damage 
rather than during the period of reperfusion-induced 
arrhythmogenesis. However, the washout of lysophospholipids by 
reperfusion may prevent the resynthesis of membrane phospholipids
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(reviewed by van der Vusse and Reneman, 1985), although the role of 
membrane repair in protection against reperfusion arrhythmias is 
speculative.
1.5.3 Catecholamines and Adrenergic Neural Activity
Clinical observations correlating increased sympathetic drive and 
elevated plasma catecholamine levels with the incidence of VF 
(Bertel et al, 1982) have been supported by experimental evidence 
of increased noradrenaline overflow in isolated rat hearts 
following regional and global ischaemia (Schomig et al, 1982; 
Abrahams son et al, 1983). Ischaemia-induced release of myocardial 
noradrenaline is thought to occur by exocytosis of neuronal 
vesicles, although a reversal of the neuronal uptake 1 mechanism 
has been suggested (Schomig et al, 1984) after ischaemic periods of 
10 min or more. Evidence associating sympathetic overactivity and 
elevated noradrenaline levels with arrhythmogenesis is equivocal; 
systemic administration of catecholamines has been shown to 
exacerbate or reduce arrhythmias during ischaemia (Harris et al, 
1971), whilst chronic cardiac sympathetic denervation affords some 
protection (Fowlis et al, 1974). Chemical sympathectomy also 
reduces the incidence of ischaemic arrhythmias (Sheridan et al,
1980; Daugherty et al, 1986).
Attempts to reduce ischaemia-induced arrhythmias with beta-receptor 
blockade have produced conflicting results. Where antiarrhythmic 
protection is achieved, interpretation of data is complicated by
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other non-specific actions of the beta-receptor antagonists used. 
Daugherty et al (1986) found both optical isomers of propranolol 
to be equipotent in suppressing arrhythmias, suggesting the 
involvement of a local anaesthetic (class I) antiarrhythmic 
mechanism. The results of a study by Curtis et al (1985) led the 
authors to suggest that beta-blockers may protect against 
arrhythmias by elevating the extracellular potassium concentration 
rather than by myocardial receptor blockade. Protection against 
reperfusion arrhythmias using propranolol (Sheridan et al, 1980), 
oxprenolol and timolol (Manning et al, 1983) has not been 
demonstrated, suggesting that activation of the adenylate cyclase 
system via beta-receptor stimulation is not involved in reperfusion 
arrhythmogenesis.
The alpha-adrenoceptor antagonists phentolamine and prazosin have 
been shown to be effective in reducing reperfusion arrhythmias 
(Sheridan et al, 1980). Corr and colleagues (1981) demonstrated 
enhanced alpha-receptor responsiveness in the cat myocardium and it 
has been argued (Corr and Witkowski, 1983) that increased 
alpha-receptor stimulation leads to changes in cardiac automaticity 
and may account for the increased idio- ventricular rate observed 
during reperfusion in cats (Sheridan et al, 1980). Alternative 
mechanisms have also been ascribed to the antiarrhythmic actions of 
phentolamine and prazosin. Electrophysiological studies on isolated 
heart tissues confirmed the local anaesthetic properties of 
phentolamine (Northover", 1983; Daugherty et al, 1986) and prazosin 
(Dukes and Vaughan-Williams, 1984). Phenoxybenzamine and 
trimazosin, alpha-receptor antagonists devoid of local anaesthetic
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properties, did not significantly affect the occurrence of 
ischaemia-induced arrhythmias in the isolated rat heart (Daugherty 
et al, 1986).
The role of sympathetic activation in arrhythmogenesis therefore 
remains to be resolved. The relevance of elevated levels of 
myocardial catecholamines is subsequently difficult to determine. 
The evidence discussed above, together with the recent finding that 
the angiotensin converting enzyme inhibitors captopril, enalapril 
and ramiprilat, reduce noradrenaline overflow upon reperfusion of 
isolated rat hearts and protect against reperfusion arrhythmias 
(Linz et al, 1986; van Gilst et al, 1986), strongly support the 
view that catecholamines are arrhythmogenic under conditions of 
ischaemia and reperfusion. The possibility that noradrenaline is 
arrhythmogenic via a free radical-mediated mechanism is discussed 
later.
1.6 FREE RADICALS AND ARRHYTHMDGENESIS
Interest in free radical reactions has increased over the last 20 
years to the extent that free radicals have been implicated as 
participants in a wide range of biological mechanisms including 
cancer (Oberley, 1982), ageing (Pryor, 1978), acute inflammation 
(Petrone et al, 1980), radiation damage (Misra and Fridovich, 1976) 
and ischaemia/reperfusion-induced damage (see below). Significant 
progress has been made in the understanding of mechanisms ’by which 
free radicals are generated and propagated, particularly those 
derived from molecular oxygen (O2). The following considers the
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importance of free radicals in ischaemia/reperfusion injury, with 
particular emphasis on the role of active oxygen metabolites in the 
generation of cardiac ventricular arrhythmias.
1.6.1 Definition,Types and Production of Oxygen Free Radicals
A free radical is defined as any species that independently exists 
with one or more unpaired outer electrons. This definition includes 
the hydrogen atom, most transition metals and O2 itself, which has 
2 unpaired electrons and so is referred to as a biradical. O2 is a 
relatively slow reacting molecule. Its 2 outer electrons have 
parallel spins; this makes donation of another pair of electrons 
difficult, since most electron pairs have antiparallel spins. 
Addition of an electron pair would therefore require spin inversion 
of one O2 electron, a process that takes a relatively long time 
compared to the lifetime of a collision complex. This phenomenon, 
known as "electron spin restriction", tends to result in one 
electron (univalent) additions to O2 . In mitochondria, O2 is 
reduced tetravalently (4 electron addition) by virtue of enzyme 
systems that contain transition metals capable of accepting and 
donating single electrons (e.g. cytochrome oxidase). Even under 
normal aerobic conditions however, some univalent reduction 
occurs, giving rise to the active oxygen species superoxide (O2 •"), 
hydrogen peroxide (H2O2 ), hydroxyl radical (OH -) and finally water, 
as in equation 1;
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e~ e~ +2H+ e~ + H+ e~ + H+
02— -^>0 2 ----- —^---->H202--- — ^--*0H------—^ --->H20 equation 1
A condition that would favour the univalent pathway, and so the 
generation of oxygen free radicals, is the saturation of 
respiratory chain carriers situated on the inner mitochondrial 
membrane. This, in turn, would be brought about by an increased 
availability of reducing agents (Turrens et al, 1982).
1.6.2 Mechanisms of Free Radical Generation
Apart from the univalent reduction of oxygen outlined above, there 
are several other biological sources of 02-“. The first documented 
source was xanthine oxidase (McCord and Fridovich, 1968). 
Hypoxanthine and xanthine are metabolised in cells by virtue of 
the catalytic properties of the NAD+-dependent dehydrogenase form 
of xanthine oxidase. Under certain conditions (extreme temperature 
and anoxia, and in the presence of proteolytic and sulphydryl 
oxidising agents), the dehydrogenase (D) form is converted to the 
oxidase (0) form (Parks and Granger, 1986). Xanthine oxidase acts 
as an electron acceptor in the catabolism of hypoxanthine and 
xanthine, using O2 as the electron source. The removal of one 
electron from O2 produces 02-".
0 2 -“ may also be formed by the autoxidation of biological molecules 
including glyceraldehyde, cysteine and catecholamines. At 
physiological pH, the rates of oxidation of adrenaline and 
noradrenaline are slow, even in the presence of physiological
23
concentrations of transition metals (catalysts of free radical 
generation; see below) (Halliwell and Gutteridge, 1985). However, 
higher concentrations of metal catalysts such as iron (Fe3+ and 
Fe2+) and copper (Cu2 + ) accelerate this process and enhance free 
radical production. Of particular biological relevance is the 
oxidation of haemoglobin to oxyhaemoglobin. The former contains 
iron in its reduced (Fe2 + ) form which, when attached to O2 , loses 
an electron resulting in the formation of an Fe3+-02-- complex.
Such reactions occur in approximately 3% of human haemoglobin every 
day and so provide a constant flux of 02-" (Halliwell and 
Gutteridge, 1985).
O2 • ~ is also used to the body's advantage. The bactericidal action 
of blood-borne neutrophils is thought to involve the chemotactic or 
physical stimulation of an NADPH oxidase complex in the plasma 
membrane of the phagocytic cell (Babior, 1978). Activation of this 
complex triggers the uptake of O2 by the neutrophil, a process 
known as the "respiratory burst". NADPH is used as an electron 
source for the reduction of O2 to form 02*" (equation 2);
NADPH + 202---- »NADP+ + H+ + 202•" equation 2
In the aqueous interior of cells and cell organelles, 02-" 
undergoes spontaneous "dismutation" (equation 3);
202'- + 2H+-----»H202 + O2 equation 3
The rate of this reaction is slow (Km<0.3 H~1s-1), but is
24
accelerated by acidic conditions and in the presence of enzyme 
catalysts, antioxidants and transition metals (Halliwell and 
Gutteridge, 1985). Equation 1 shows that any system which generates 
O2 • ■ must also produce H2O2 , unless 02-" is removed from that 
system. H2O2 has no unpaired electrons and so is not strictly a 
free radical, although it is often classed as such because of its 
involvement in the production of OH • from O2 • ".
Hbmolytic fission of the 0-0 bond in H2O2 produces two OH- 
radicals, a process which is achieved by heat or ionising radiation 
(Halliwell and Gutteridge, 1984). The participation of transition 
metals in OH- formation is more physiologically relevant. In 1894, 
Fenton first described a role for iron in a reaction known as the 
Fenton reaction, as described by Halliwell and Gutteridge (1984) 
(equation 4);
Fe2+ + H2O2  ^Fe3+ + OH- + OH" equation 4
The reaction between O2 • ” and H2O2 was also postulated as a 
mechanism of OH- production (Haber and Weiss, 1934) and is known as 
the Haber-Weiss reaction (equation 5);
02*"+ H2O2  >02 + OH- + GH- equation 5
Although the rate constant for the above reaction is vitually zero 
in aqueous solution (Halliwell and Gutteridge, 1984), the mechanism 
is plausible in the presence of transition metals such as iron.
This "iron-catalysed Haber-Weiss reaction" involves the reduction 
of Fe3+ ions by 02-" followed by the Fenton reaction, and is shown
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in equations 6 and 7;
Fe3+ + 02-~ »Fe2+ + O2 equation 6
Fe2+ + H2O2----- >Fe3+ + OH- + QH“ equation 7
The importance of transition metals in oxygen radical generation is
therefore apparent and it is not surprising that the body uses
iron-binding proteins (transferrin, lactoferrin and ferritin) to 
keep the 'non-protein-bound (free) iron pool as small as possible 
(Halliwell and Gutteridge, 1984).
1.6.3 Oxygen Radical-mediated Damage and Cellular Defence
Mechanisms
0 2 -" itself has the capacity to attack the biologically ubiquitous 
carbonyl (C = 0) group, and so could be extremely damaging to 
membrane phospholipids. However, as was shown by equation 3, O2 •" 
undergoes spontaneous dismutation, the rate of which is increased 
by the catalytic action of endogenous enzymes called superoxide 
dismutases (SOD's) (MeCord and Fridovich, 1968). SOD's are proteins 
containing metal groups. In mammals, two types of SOD are thought 
to be important in O2 • * dismutation; Cu-Zn SOD and Mn SOD 
(Steinman, 1982). The former is mainly a cytosolic enzyme but has 
also been located in lysosomes and between the inner and outer 
mitochondrial membranes. Mn SOD is located in the mitochondrial 
matrix. The active sites of Cu-Zn SOD and Mn SOD, Cu2+ and Mn3 + 
ions respectively, undergo the reaction sequence shown in equations 
8 and 9;
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Enzym e-M n+ + 0 2 - " ------------► Enzyme-M< n ~1 ) + + O2 e q u a tio n  8
E nzym e-M (n -1  >+ + 0z-~ + 2H+-----»Enzym e-M n+ + H2O2 e q u a tio n  9
where M represents the metal atom
SOD's are specific for O2 • ~ only, and the rate of the catalysed 
dismutation reaction is of the order of 5x105 M-1s_1. It is 
therefore unlikely that 0 2 -“ is responsible for much oxygen 
radical-mediated damage to biological systems f The product of O2 
dismutation, H2O2 , is a weak oxidizing agent capable of oxidizing 
thiol (-SH) groups and in doing so may inactivate thiol-containing 
enzymes (Halliwell and Gutteridge, 1985). However, most aerobic 
cells possess catalases, located mainly in subcellular organelles 
called peroxisomes, which catalyse the reduction of H2O2 to water 
(equation 10);
2H2O2------------»2H20 + O2 e q u a tio n  10
Mairmals also possess glutathione peroxidase, an enzyme which 
utilises the low molecular weight thiol compound glutathione 
(present in cells in mM quantities as the reduced form, GSH) to 
reduce H2O2 (equation 11);
H2O2 + 2GSH — GSSG + 2H2O e q u a tio n  11
This enzyme system is thought to be important in cellular 
locations, such as mitochondria, where catalase activity is either 
very low or absent (Kosower and Kosower, 1978). When both catalase
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and glutathione peroxidase systems are available, the enzymes are 
thought to "co-operate"; as the concentration of H2O2 increases, 
catalase activity increases to take-over from glutathione 
peroxidase in removing H2O2 (Halliwell and Gutteridge, 1985). The 
importance of co-operativity is apparent when the GSH regeneration 
pathway is considered;
NADP+
NADPH >v . GSSG ft JR2O
\ /  *\/<
GR GPx scheme 1
GSH H2O2
As was seen in equation 11, the reduction of H2O2 by glutathione 
peroxidase (GPx) at the expense of GSH produces oxidised 
(disulphide) glutathione, GSSG. The regeneration of GSH from GSSG 
(scheme 1 above) is achieved using the enzyme glutathione reductase 
(GR), which utilises reduced nicotine adenine dinucleotide 
phosphate (NADPH) produced by the pentose phosphate pathway (PPP). 
The rate limiting step of the PPP is the dehydrogenation of 
glucose-6-phosphate to 6-phosphogluconate, a reaction catalysed by 
glucose-6-phosphate dehydrogenase (G-6-PDH). If the rate of H2O2 
production exceeds the capacity of G-6-PDH to produce NADPH, then 
the GSH/GSSG ratio falls (Kosower and Kosower, 1978).
The endogenous mechanisms for "scavenging" O2 •" and H2O2 would, 
under normal physiological conditions, be expected to protect cells 
against oxygen radical damage. However, if these mechanisms are 
perturbed or overwhelmed by excessive free radical production, OH* 
is produced by the transition metal-catalysed Fenton and
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Haber-Weiss reactions (equations 6 and 7). Since OH- is the most 
reactive biologically-produced chemical species known (Halliwell 
and Gutteridge, 1985), the production of OH- is potentially lethal 
to cells. OH- undergoes 3 main types of reaction (Willson, 1978); 
hydrogen abstraction, addition and electron transfer. In cells, CH- 
removes hydrogen from the lipids of membranes to produce lipid 
peroxides, as illustrated below;
Lipid-H + CH---- >Lipid- + H2O equation 12
Lipid- + O2 ----»Lipid-0-0 • equation 13
Lipid-O-O- + Lipid-H ^Lipid-O-O-H + Lipid- equation 14
Initiation (equation 12) of the lipid peroxidation sequence, the 
abstraction of hydrogen by CH-, is proceeded by the formation of 
lipid peroxy radicals (Lipid-O-O-, equation 13) by the reaction of 
oxygen with a conjugated diene (i.e. Lipid- following electron 
rearrangement). Peroxy radicals combine with hydrogen atoms on 
other lipid molecules, resulting in the formation of lipid 
hydroperoxides (Lipid-O-OH, equation 14). The lipid peroxidation 
process has been extensively reviewed by Halliwell and Gutteridge 
(1985, chapter 4).
Peroxidation of membrane lipids perturbs the structure and function 
of membranes; changes in fluidity, surface charge, electrical 
stability and ion permeability have all been demonstrated (see 
Kako, 1985, for review). Membrane-bound enzyme systems, such as 
sodium-potassium ATPase, calcium ATPase and adenylate cyclase, are 
similarly disturbed (Stekhoven and Bonting, 1981). Protection
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against such damage is therefore essential for normal cellular 
function and as a consequence, several other defence mechanisms 
exist in addition to those previously considered. Vitamin C 
(ascorbic acid) and vitamin E (alpha-tocopherol) are lipid soluble 
molecules located in biological membranes which react with OH- and 
lipid peroxy radicals to produce other less reactive radical 
species (Freeman and Crapo, 1982). Similarly, GSH can react 
directly with OH- (Halliwell and Gutteridge, 1985).
Under normal physiological conditions, it vrould appear that cells 
possess adequate enzymatic and antioxidant defence mechanisms to 
protect against the deleterious effects of active oxygen 
metabolites. Many authors (Meerson et al, 1982; Hess and Manson, 
1984; Otani et al, 1984; hfcCord, 1985; van der Vusse and Reneman, 
1985; Vfoodward and Zakaria, 1985; Bernier et al, 1986; Wems et al, 
1986) have proposed that such mechanisms are overwhelmed by 
accentuated radical production in the setting of myocardial 
reperfusion. The following paragraphs will therefore consider the 
hypothesis that oxygen free radicals are generated during ischaemia 
and/or reperfusion of the heart and contribute to the pathogenesis 
of life-threatening cardiac arrhythmias.
1.6.4 Free Radical Generation in the Ischaemic/Reperfused Heart
Several changes that occur during ischaemia/reperfusion have the 
potential to increase the extent of free radical formation (table 
1.6.4). In ischaemic cells, the decrease in O2 available for the
1: ACCUMULATION OF REDUCED METABOLITES
2: MITOCHONDRIAL DAMAGE
3: CALCIUM OVERLOAD
4: ARACHIDGNIC ACID METABOLISM




Putative sources of oxygen free radicals in the ischaemic reperfused 
heart.
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tetravalent respiratory pathway inhibits the terminal component of 
the respiratory chain, cytochrome oxidase (Meerson et al, 1982).
Any available O2 dissolved in the lipid matrix of cell membranes 
would therefore tend to be utilised by the univalent pathway. 
Reduced metabolites such as NADH accumulate under ischaemic/hypoxic 
conditions (Opie, 1978; Meerson et al, 1982) as a result of an 
initial increase, followed by cessation, of anaerobic glycolysis 
and so provide a source of electrons for univalent O2 reduction.
The reintroduction of O2 to this system (during reperfusion, for 
example) would provide an abundant supply of substrate for the 
univalent pathway (particularly if mitochondria are damaged, see 
below) and may enhance the formation of oxygen radicals. Inhibition 
of cytochrome oxidase with cyanide has indeed been shown to enhance 
02-- formation (Chance et al, 1977; Turrens et al, 1982).
Since mitochondria are the major site of cellular oxidation 
reactions, it seems reasonable to suppose that they are also the 
main site for the generation of oxygen radicals. Indeed, Guamieri 
et al (1985) demonstrated that sub-mitochondrial particles from 
ischaemic rabbit heart produce more O2 •~ than those from normal 
heart. In an earlier publication, Guamieri and co-workers (1983) 
exposed rat heart mitochondrial preparations to 0 2 -" generated by 
the xanthine/xanthine oxidase system and observed a reduced ability 
to utilise anaerobic glycolytic substrates. The authors proposed 
that inhibition of this energy production pathway would lead to 
univalent O2 reduction1 and consequently the production of more 
oxygen radicals. Under conditions of saturated mitochondrial 
(tetravalent) respiratory function, hyperoxia or an increase in O2
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tension leads to univalent O2 reduction and free radical generation 
(Freeman and Crapo, 1981; Turrens et al, 1982). During no-flow 
ischaemia, the initial increase in anaerobic glycolysis is 
inhibited by the accumulation of lactate and pyruvate in the 
ischaemic tissue (Neely and Feuvray, 1981) and the ensuing decrease 
in ATP synthesis inevitably slows-down energy-dependent processes 
such as those involved in the maintenance of myocardial ion 
gradients. Increases in mitochondrial potassium efflux (Masini et 
al, 1984) and mitochondrial calcium overload (Hess and Manson,
1984; Nayler, 1981) have been described under ischaemic conditions. 
At present, a definitive causal effect relationship between free 
radical generation, mitochondrial damage and mitochondrial calcium 
overload during ischaemia and reperfusion is lacking. Whilst free 
radical-induced mitochondrial damage m y  predispose to 
mitochondrial calcium overload, it is equally possible that 
mitochondrial calcium overload enhances free radical production by 
inhibiting mitochondrial oxidative phosphorylation (Braughler et 
al, 1985). Despite this lack of clarity, the fact remains that 
reoxygenation of anoxic myocardium is associated with structural 
(Hearse et al, 1985) and functional (Opie, 1978) damage to 
mitochondria, which in conjunction with the protective effect of 
free radical scavengers on mitochondrial function (Guamieri et al, 
1978), strongly implicates mitochondria as a prime source of oxygen 
free radicals during myocardial reperfusion.
The release and accumulation of prostanoids during myocardial 
ischaemia was considered earlier (section 1.5.1). Whilst the 
arrhythmogenic role of prostanoids is not fully understood, the
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ischaemia-associated metabolism of arachidonic acid to 
prostaglandins and leucotrienes (Coker et al, 1981) generates 
electrons capable of initiating free radical formation (Rowe et 
al, 1983). Indeed, Khuel and colleagues (1980) observed the 
production of a powerful oxidant, probably OH-, during the 
conversion of prostaglandin G2 to prostaglandin H2 . 
Calcium-activated phospholipases stimulate arachidonic acid 
metabolism (Blackwell and Flower, 1983) and it has been suggested 
(van der Vusse et al, 1982) that reperfusion-induced calcium 
overload may be related to oxygen radical formation by this 
mechanism.
Elevated levels of catecholamines, particularly noradrenaline, 
during ischaemia (section 1.5.3) may provide an additional source 
of oxygen radicals during reperfusion. Catecholamine autoxidation 
makes available electrons for the reduction of O2 . Evidence in 
support of such a mechanism was presented by Singal and colleagues 
(1983), who were able to protect against isoprenaline-induced 
myocardial damage in vitamin E-deficient rats by supplying a 
dietary source of the vitamin.
The xanthine/xanthine oxidase system is frequently used for the 
experimental generation of oxygen free radicals. This system was 
first characterised by McCord and Fridovich (1968). The presence of 
endogenous xanthine oxidase has been demonstrated in many tissues 
(McCord, 1984), predominantly as the dehydrogenase form (Schoutsen 
et al, 1983). Xanthine dehydrogenase catalyses the metabolism of 
hypoxanthine and xanthine to uric acid using NAD+ as an electron
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acceptor and so does not produce free radicals (Chambers et al,
1985). Evidence suggests that under certain pathological conditions 
such as myocardial ischaemia (Chambers et al, 1985; Granger et al,
1986), the dehydrogenase is converted to the oxidase by proteolysis 
(McCord, 1985) and/or sulphydryl oxidation (Waud and Rajagopalan, 
1976). Xanthine oxidase catalyses the same reactions as the 
dehydrogenase, the important difference being its use of O2 as an 
electron acceptor. Therefore, xanthine oxidase-catalysed reactions 
produce O2 •~. That xanthine oxidase is a physiological source of 
oxygen radicals is now generally accepted. Dehydrogenase to oxidase 
conversion during myocardial ischaemia, followed by the 
introduction of O2 during reperfusion, provide ideal conditions for 
xanthine oxidase-derived oxygen radical production. The involvement 
of endogenous xanthine oxidase in reperfusion damage is considered 
further in chapter 6.
)
The contribution of the O2 •"-producing action of phagocytic cells 
to ischaemic damage has also been proposed (Engler et al, 1983; 
Romson et al, 1983; Mullane et al, 1984). Following the onset of 
myocardial ischaemia, the myocardium is invaded by activated 
neutrophils as part of the inflammatory process (Romson et al,
1983; Mullane et al, 1984). The 02*" released by these cells may 
contribute to myocytolysis although the duration of the migration 
process is critical to such a role. A 17-fold increase in the 
neutrophil content of the myocardium has been observed 24 hours 
after infarction (Romson et al, 1983), whereas Engler and 
colleagues (1983) could not demonstrate any neutrophil migration 
following 5 hours of ischaemia. The role of neutrophils in
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mediating oxygen radical-derived damage during early ischaemia is 
therefore unresolved and evidence for such a role in reperfusion 
arrhythmogenesis is lacking (Vfoodward and Manning, 1987). The 
ability to induce reperfusion arrhythmias in isolated hearts, in 
which there are likely to be very few if any neutrophils present, 
would further suggest that neutrophils are not a major factor in 
the initiation of these arrhythmias.
In summary, many physiological mechanisms exist with the potential 
to generate damaging free radicals. Circumstantial evidence 
suggests that conditions of ischaemia and reperfusion are conducive 
to the involvement of such mechanisms and their contribution to 
reperfusion-induced arrhythmogenesis should be a prime 
consideration in studies of ischaemic heart disease and sudden 
cardiac death.
1.7 OBJECTIVES OF THE PRESENT STUDY
The following study was aimed at evaluating the working hypothesis 
that reperfusion arrhythmias are associated with mechanisms 
involving the generation of oxygen free radicals. The aims of 
individual experiments are detailed in the appropriate chapters, 
but can be integrated into the following main objectives;
(1) to confirm that reperfusion of regionally ischaemic isolated 
rat hearts evokes ventricular arrhythmias;
(2) to demonstrate that reperfusion arrhythmias are accompanied by 
the production of oxygen free radicals;
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(3) to demonstrate that free radical scavengers prevent or reduce 
the development of ventricular arrhythmias;
(4) to investigate the importance of potassium ion fluxes to 
arrhythmogenesis and the effect of free radical generation on 
potassium efflux from hearts;
(5) to. investigate the role of putative free radical generating 




2.1 THE ISOLATED RAT HEART PREPARATION. REGIONAL ISCHAEMIA AND 
REPERFUSION
Hearts from male wistar rats (200g to 300g, University of Bath
strain) were canulated via the aorta and perfused retrogradely at a
constant flow of 10ml /min with a bicarbonate buffer of the
following composition (mM):
(0 \uo |t>
NaCl, 118;KC1,4.7;KH2PO4 ,1.2;MgS04,1.2;NaHC03,25;CaCl2,1.2;D-glucose, 11.1. <■
i(j 0 if 2
The perfusion fluid was gassed with 95%02/5%C02 and was of pH 7.4
fo,
at 37°C. During preparation of the perfusion fluid, the
\£<a f
* I ? ^
precipitation of calcium was carefully avoided and removal of ?er-t < 
particulate matter from all solutions was facilitated by on-line 
filtration. Immediately after the heart was mounted, a loose suture 
was placed around the left anterior descending coronary artery 
close to its origin. Both ends of the ligature were passed through 
a short polythene tube to form a snare. Regional ischaemia could be 
induced by pulling the suture whilst pressing the tube against the 
myocardial surface, where it was held in place with a small clip. A 
sustained increase in perfusion pressure indicated successful 
coronary artery ligation (CAL). Reperfusion (REP) could be 
initiated by unclipping and removing the tube; a decrease in 
perfusion pressure indicated successful reperfusion. Further 
evidence of successful ligation was obtained at the end of each 
experiment, when hearts were perfused with disulphine blue and the 
ligation procedure repeated. Electrocardiogram (ECG) electrodes
A-
were placed on the epicardial surface of the right atrium and left 
ventricle and ECG1 s were monitored on a Narco Trace (Narco 
Biosystems, USA) oscilloscope. Tension developed from a diastolic
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load of 2g was recorded via a Devices UF1 isometric transducer 
attached by cotton thread and fine nickel hooks to the apex of the 
left ventricle. The tension recording was also used to trigger a 
Devices 4521 rate meter in order to monitor heart rate. Perfusion 
pressure was monitored using a Bell Howell 4-442 pressure 
transducer. Each parameter was recorded on a Gould 2400S 4 channel 
recorder. Developed tension was recorded simultaneous with ECG's on 
a Devices MX216 2 channel recorder at a fast chart speed.
2.1.1 Drug Perfusion Protocol
Hearts were allowed an initial equilibration period of 15 min, 
during which standard perfusion medium was used. For the following 
5 min, the composition of the perfusion fluid was changed by 
switching to a reservoir containing bicarbonate buffer with a 
potassium concentration of 3.2mM in order to enhance the 
development of reperfusion-induced arrhythmias (Woodward and 
Zakaria, 1983). During this period, drug-free control values for 
contractility, heart rate and perfusion pressure were recorded. 
Hearts were then perfused with the drug under investigation 
(solubilised in low potassium buffer) for 5 min, following which 
CAL was induced for a further 10 min. The effects of reperfusion 
were then studied for 3 min, during which time epicardial ECG's 




Hypoxia was induced either 2 min before CAL or 2 min before 
reperfusion. Since no drug was being used, hearts were perfused 
with low potassium perfusate throughout the experiment after the 
initial equilibration period. Perfusion fluid was rendered hypoxic 
by gassing with 95% N2/5% CO2 .
2.1.3 Perfusion with "Arrhythmogenic" Solution
In experiments designed to induce arrhythmias using an 
"arrhythmogenic" solution, hearts were perfused with a buffer in 
which the concentrations of KCl and MgrSCU were reduced to 1. 2mM and 
zero respectively, and the CaCl2 concentration was increased to 
4.9mM. Arrhythmogenic perfusion commenced 5 min after perfusion 
with low potassium buffer. Ventricular fibrillation (VF; see 
section 2.3) occurred 220+11 sec after arrhythmogenic perfusion 
began (n=5).
2.2 DETERMINATION OF POTASSIUM EFFLUX USING THE RADIOACTIVE TRACER 
ION RUBIDIUM - 86 (86Rb+)
2.2.1 Experimental Protocol
Hearts were isolated and perfused as previously described (section 
2.1) . Following a 5 min equilibration period, hearts were loaded 
with 0.2 pCi/ml 86Rb+ in standard perfusion medium (5.9mM K+) for 
10 min. The next 30 min comprised a washout period under standard
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perfusion conditions, after which hearts were perfused with low 
potassium (3.2mM K+) buffer. The remainder of the experiment was as 
described in section 2.1. Radioactive perfusate samples were 
collected every 2 min when required and every 30s following 
reperfusion. At the end of the experiment, ischaemic and 
non-ischaemic areas of the heart were identified (section 2.1), 
each was blotted dry, weighed and minced with scissors. To each 
tissue sample, 5 ml 1M KQH was added and the samples were allowed 
to digest for 48 hours.
2.2.2 Treatment of Samples
To each tissue suspension, 5 ml 1M HC1 were added to neutralise the 
sample and prevent chemiluminescence interference (Durbin and 
Jenkinson, 1961) during subsequent scintillation counting. Aliquots 
of 1 ml were taken from perfusate or neutralised tissue samples, to 
which 4 ml Optiphase "Safe" scintillation cocktail were added.
After thorough mixing, samples were analysed in an LKB 1215 liquid 
scintillation counter (Durbin and Jenkinson, 1961).
2.2.3 Calculation of the Efflux Rate Coefficient (ere)
The efflux rate coefficient (ere) at time t was calculated 
according to equation 15;
ere (min-1) = perfusate count equation 15
total count x collection time (min)
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where the total count is the tissue count plus the sum of the 
perfusate counts up to time t.
In order to speed-up calculations, a computer programme was written 
(see Appendix 1).
2.3 EVALUATION OF ARRHYTHMIAS
Arrhythmic activity was assessed by counting the number of 
premature ventricular contractions (PVC's), including those defined 
as ventricular tachycardia (VT; see below), and by recording the 
incidences, onset and duration of VT and ventricular fibrillation 
(VF). Isolated PVC's were defined as discrete QRS complexes and 
were inevitably followed by a compensatory pause in electrical 
activity and an increase in the amplitude of the resultant 
contraction. VT was classified as 5 or more consecutive PVC's and 
was accompanied by a reduction in contraction amplitude. Bigeminal 
rhythms, when occuring 3 or more times consecutively, were also 
classified as VT. When discrete QRS complexes were no longer 
clearly identifiable and electrical signals exhibited chaotic 
activity with regard to amplitude, hearts were deemed to be 
undergoing VF. In such cases, contractility was greatly reduced or, 
as was usually observed, absent. An increase in resting tension 




All protein determinations were carried out using the simple and 
rapid Coomassie blue dye-binding method of Bradford (1976). 
Calibrations were made using bovine serum albumin (BSA) as standard 
protein.
2.4.2 Ferricytochrome c Reduction
Hearts were perfused with low potassium (3.2mM) buffer containing 
5x10" 5M ferricytochrome c (FeCytC). Perfusate samples were 
collected and their light absorbances measured at 550nm wavelength 
in a Pye Unicam PU8605 spectrophotometer (Goldstein et al, 1975).
The reduction of FeCytC by xanthine oxidase in the presence of 
xanthine, and investigations with agents which might affect this 
process, were carried out as below. The procedure described was 
modified from the method of Horecker and Heppel (1949). To 1ml of 
reagent mixture (comprising 1x10"5M FeCytC, 5x10"5M xanthine,
1x10"4M disodium EDTA and 5x10"2M tripotassium phosphate; pH 7.4 at 
25°C) in a cuvette, 0.05ml water (or the agent under investigation) 
was added. After mixing, the reduction of FeCytC was initiated by 
the addition of 0.05ml (0.65U) xanthine oxidase and monitored in a 
Cecil CE595 spectrophotometer coupled to a Cecil CE500 chart 
recorder at a wavelength of 550nm. The rate of the reaction was 
calculated qualitatively as the change in absorbance units per unit
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time.
2.4.3 The Determination of Lactate and Lactate Dehydrogenase (LDH)
Lactate was determined by a method similar to that of Hohorst 
(1965). To 1ml of buffer (5x10"^ glycine, 2x10" 1M hydrazinium 
sulphate; pH adjusted to 9.5 with 2M NaOH at 25°C) in a quartz 
cuvette, 0.05ml of 5x10"2M NAD and 0.1ml of sample solution were 
added. After mixing, the absorbance of the solution was read at 
340nm wavelength in a Pye Unicam PU8605 spectrophotometer with a 
deuterium light supply. 0.005ml (lOU/ml) LDH was subsequently 
added, the solution mixed and allowed to stand at room temperature 
for 30 min before a second absorbance reading was taken. The 
concentration of lactate in each sample was calculated using 
equation 16;
pmoles/ml lactate = dE x assay volume x 10 equation 16
e
where: dE is the difference between the 2nd and 1st absorbance 
readings; e is the mM extinction coefficient of NADH at 
340nm (= 6.22).
The assay for LDH was based on the same oxidation-reduction 
reaction involved in lactate determination (equation 17);
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LDH
PYRUVATE + NADH + H+------> LACTATE + NAD+ equation 17
LDH could therefore be determined by the reduction of pyruvate or
by the oxidation of lactate. The assay procedure described below •
used the latter principle. 1ml of 5xlO_1M sodium phosphate buffer 
(pH 7.6), 0.4ml of 5x10"^ L-lactate and 0.3ml of 1.4x10-2m NAD 
solution were mixed in a quartz cuvette. A 1ml aliquot of sample 
solution was added and after mixing, the absorbance of the solution 
was read at 340nm wavelength at 30s intervals for 8 min in a Pye 
Unicam PU8605 spectrophotometer with a deuterium light source.
Since 1 unit of enzyme oxidises lpmole of NAD+ per min (Eichner, 
1982), LDH activity could be calculated from the slopes of the 
resultant linear plots.
2.4.4 Removal of Aimonium Sulphate and Sodium Salicylate from the 
Commercial Preparation of Xanthine Oxidase
Although the effect on hearts of laboratory preparations of the 
vehicle for xanthine oxidase was studied, it seemed desirable to 
test the effects of the enzyme in the absence of the vehicle.
Should no apparent differences in response be observed, the 
time-consuming removal of the vehicle could be avoided. To this 
end, 1ml of xanthine oxidase was dialysed using Medicell 18/32" 
dialysis tubing in 10 litres of 0.9% saline at 4°C for 24 hr in the 
dark. Dialysis tubing was prewashed in double distilled, deionised 
water to remove metal ion and other contaminants which might have 
interfered with the enzyme's activity. Following dialysis, samples 
of enzyme were tested for activity and protein content as
44
previously described.
A second technique for removal of the vehicle, gel filtration, was 
also used. Sephadex G-25 microspheres were pre-swollen and 
suspended in 5x10“2M Tris/HCl buffer, pH 7.6 at 25°C, and a 25ml 
column was prepared. Commercial xanthine oxidase (1ml) was added to 
the column and eluted with the Tris/HCl buffer. Fractions of 1ml 
were collected and underwent qualitative protein assay by measuring 
their absorbances at 280nm. To test for the presence of ammonium 
sulphate, each fraction was subjected to a barium sulphate 
precipitation test. To 0.1ml of sample, 1ml of saturated barium 
chloride was added. The presence of sulphate was indicated by the 
appearance of a white precipitate of barium sulphate. Preliminary 
studies showed this method to be sensitive to concentrations of
2.5 CHEMILUMINESCENCE MEASUREMENTS OF XANTHINE OXIDASE AND XANTHINE 
DEHYDROGENASE IN CARDIOVASCULAR CELLS
2.5.1 Cell Culture
Neonatal cardiac myocytes in primary culture were obtained 
according to the method of Higgins and co-vrorkers (1979). They were 
purified to approximately 95% by differential adherence (von 
Tschamer and Bailey, 1983). Monolayers were maintained in 
potassium-free salt solution (NaCl, 116mM; M3SO4, ImM; CaCl2 ,
1.8mM; d-glucose, 5.6mM) containing 2% Hams F10 (xlO) medium, 10% 
HEPES, 10% foetal calf serum (FCS), 2. 5pg/ml gentamycin, 2mM
»AV^
sulphate exceeding 10" 4M.
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1-glutamine and 380pg/ml penicillin. Fibroblasts were grown from 
the same primary cell preparations. They were allowed to 
proliferate beyond confluence until, after 5 passages in the above 
medium, 100% fibroblasts were identified morphologically.
Rat aortic vascular smooth muscle (vsm) cells were obtained from 
PLHS Centre of Applied Microbiology and Research, Porton Down 
(U.K.) as a pure cell line (A10) stored in liquid nitrogen. They 
were cultured for up to 5 passages in Dulbecco's Modified Eagles 
Medium (DMEM) containing 10% FCS, 2mM 1-glutamine and lOpg/ml 
gentamycin.
Adult rat myocytes were prepared from male Wistar rats (260-300g; 
Alderley Park Strain, I.e.I., U.K.) using the method of Powell and 
co-workers (1980). Cell yield was typically 3x105/ml/heart of 50% 
to 80% striated, rod-shaped cells. Cells were used imnediately 
after the assessment of density, morphology and viability (trypan 
blue exclusion).
Endothelial cells were prepared from human umbilical vein as 
described by Gimbrone et al (1974). They were passaged for up to 2 
weeks in Medium 199 containing 10% sterilised fresh human serum, 
10% FCS, 50ng/ml fibroblast growth factor, 2mM 1-glutamine and 
5pg/ml gentamycin.
All cells were maintained at 37°C in 150ml Costar flasks in an 
incubator (LEEC mark II). Neonatal and adult myocytes were 
maintained in an air-equilibrated atmosphere. All other cells were
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equilibrated with 5% CO2 . Cells were grown to conf luency in 9cm2 
single culture dishes (Costar).
Photons emitted by chemiluminescence were detected using a 52mm EMI 
9635QA phototube operating at 1050 volts in the negative ground 
configuration to reduce corona effects. Luminol 
(5-amino-2,3-dihydro-l,4-phthalazinedione), the agent used to 
enhance the signal, has an emission maximum at 425nm wavelength 
(Miura and Ogiso, 1985). The phototube used was sensitive to 
wavelengths below 570nm. The phototube was cooled to 4°C in a FACT 
50 mark III cooler, with a quartz double window separating it from 
the sample compartment below. The distance between the phototube 
and the cells was 50mm, the minimum allowing a rotational access of 
the culture plate to the light-tight sample compartment. Phototube 
emission was fed via a very short (10cm) co-axial lead to an 1121A 
amplifier-discriminator and then to an 1109 photon counter (both 
from E.G. and G.Princeton Applied Research). The response time of 
the detection system, typically 3ns, compared well with the rise 
time of the phototube, 10ns. Discrimination thresholds were set 
daily by observing the pulse height analyser output of the 1121A on 
an oscilloscope. Data were collected in the single window mode at 
ambient temperature (19°C).
2.5.2 Chemiluminescence Detection
o — >  - .
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2.5.3 Protocol for Measurement of Xanthine Oxidase/Dehydrogenase in 
Cell Preparations
Cell monolayers were introduced into the sample compartment in 2ml 
of the appropriate medium containing 4x10" 4M xanthine and 40]il of 
2mg/ml luminol. Cells were then lysed by the addition of 40pl of 1% 
(v/v) Triton-XlOO in double distilled, deionised water and the 
chemiluminescence immediately measured for 10 consecutive periods 
of 10s. 40]il of 5x10"3M 5,5 -dithiobis-2-nitrobenzoic acid 
(DTNB) in phosphate buffered saline was then added to oxidise any 
dehydrogenase present to the oxidase (Waud and Rajagopalan, 1976) 
and the measurements were repeated. Finally, 5mU (40pl) of xanthine 
oxidase was added as a positive control. Measurements on adult 
myocytes were performed in suspension, the cells being resuspended 
in medium containing xanthine after harvesting at 300rpm for 1 min. 
Experiments on endothelial cells were repeated in the presence of 
10"6M oxypurinol, an inhibitor of xanthine oxidase.
All experiments were performed in triplicate unless otherwise 
stated. Enzyme activities were expressed per unit of cell protein 
following protein determination as previously described. Cell 
samples were randomly assigned prior to each chemiluminescence 
experiment.
The antioxidant properties of each medium were compared by 
challenging samples with 15mU xanthine oxidase in the presence and 
absence of lOU/ml superoxide dismutase (SOD), and in separate 
experiments by measurement of the rate of reduction of FeCytC
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induced by xanthine oxidase in the presence and absence of each 
medium (see section 2.4.2).
2.6 STATISTICAL ANALYSIS
Results are expressed as the mean ± the standard error of the mean 
unless otherwise specified. Changes in haemodynamic parameters were 
compared to pre-treatment values using Student's paired t-test. 
Differences from control values of the number of PVC's and the 
onset and duration times of both VT and VF were analysed using the 
Mann-Whitney U test. The incidences of VT and VF in control and 
treated groups were compared by Fischer's Exact test. Regression 
lines were fitted by least squares analysis where appropriate. The 
efflux of 86Rb+ following reperfusion was analysed by plotting ere 
against time and measuring the area bounded by the curve for the 
first 3 min of reperfusion and by the pre-reperfusion baseline 
(calculated as the mean of the pre-reperfusion values). Mean ± sem 
values of area (in arbitrary units, au) and peak ere were 
calculated for each experimental group, and comparisons between 
control and treated group means were made using the Mann-Whitney U 
test.
Statistical significance was assumed for all tests when the 
probability of the difference occurring by chance was equal to or 
less than 5% (i.e. p<0.05).
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2.7 THE HOUSING AND FEEDING OF ANIMALS
All rats were housed 10 to a cage and were constantly supplied with 
standard rat chow and tap water. Animal house lighting was set for 
an 8 hr light-8hr dark cycle.
2.8 EXCLUSION CRITERIA FOR HEART PREPARATIONS
As previously stated (section 2.1), isolated perfused heart 
preparations were allowed an initial equilibration period of 
usually 15 min. If, at the end of this period, heart rate,perfusion 
pressure and contractility were not stable, the experiment was 
terminated. Although excluded hearts were not recorded, it should 
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3.1 INTRODUCTION: THE ISOLATED RAT HEART AS AN EXPERIMENTAL MDDEL 
OF MYOCARDIAL ISCHAEMIA/REPERFUSIGN
As with all experimental models, no species is ideal for the 
comparison of physiological and pharmacological responses in Man. 
However, small animals such as the rat are regularly used in 
studies where large experimental numbers are required. The low 
collateral flow observed in the rat heart allows induction of a 
rapid and almost complete ischaemia following coronary artery 
occlusion (Schaper, 1984), a situation analagous to that which may 
be expected in a young human heart undergoing sudden coronary 
thrombosis or spasm. Whilst in vivo studies of hearts in situ may 
be more clinically relevant to the human situation, isolated rat 
hearts have frequently been used to investigate ischaemia/ 
reperfusion arrhythmias (Lubbe et al, 1978; Woodward and Zakaria, 
1983; Hearse and Tosaki, 1987), since this model is free from
r
extracardiac nervous reflexes and the influences of the general 
circulatory system. Although rat hearts are abnormal in that they 
do not exhibit an isoelectric ST segment (owing to the absence of a 
prolonged plateau phase of the action potential) and in their 
ability to spontaneously defibrillate (possibly related to their 
small size and hence relatively few electrical wavefronts) (Botting 
et al, 1986), they have continually proved to be a reliable and 
useful model for the study of arrhythmias.
The experiments detailed in this chapter were aimed at establishing 
control values for haemodynamic (described in subsequent chapters) 
and arrhythmia parameters during ischaemia and reperfusion in the
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isolated rat heart. The effects of ischaemia and reperfusion on the 
efflux of potassium were monitored using 86Fb+ as a radioactive 
marker for potassium. Since reperfusion is inevitably accompanied 
by the washout of substances accumulated in the ischaemic zone, a 
study was made of the time course of washout by measuring the 
appearance of lactate in coronary effluent. Myocyte damage was 
evaluated by measuring the release of the intracellular enzyme 
lactate dehydrogenase (LDH). It has already been mentioned that the 
xanthine/xanthine oxidase system is often used to produce oxygen 
free radicals (McCord and Fridovich, 1968), and the effects of this 
system on 86Rb+ efflux were also investigated.
The rationale for measuring changes in the rate and magnitude of 
86Rb+ (potassium) efflux may be apparent when the potentially 
arrhythmogenic effects of these changes are considered. As briefly 
mentioned in chapter 1, several characteristics of non-nodal tissue 
action potentials, particularly the resting membrane potential, 
depend upon the relative potassium concentrations of the 
intracellular and extracellular compartments. Changes in the 
extracellular potassium concentration alter the potassium 
conductance of the sarcolemma (Weidmann, 1956), which in turn 
affects the plateau duration and the slopes of rapid repolarisation 
(phase 3) and spontaneous depolarisation (phase 4). Any combination 
of these changes may be arrhythmogenic or antiarrhythmic (Gettes, 
1981).
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3.2 RESULTS: THE ISOLATED PERFUSED RAT HEART. EFFECTS OF 
REPERFUSION FOLLOWING 10 MINUTES REGIONAL ISCHAEMIA
During the course of this study, the order of experiments was 
randomised to reduce the effects of daily variations in 
experimental conditions. This in turn necessitated the pooling of 
data for each experimental group, which for control hearts meant 
pooling data obtained over a period of approximately 2 years. 
However, statistical comparisons between control groups revealed 
insignificant differences between mean values of the parameters 
measured. For reasons of practicality, treatment groups were 
therefore compared with a single, large control group (n=43).
3.2.1 Reperfusion-induced Arrhythmias in Control Hearts
On reperfusion of control hearts, the incidences of VT and VF were 
86% and 72% respectively. The mean onset of the first episode 
occurred after 6+ls for VT and 13+2s for VF, with a total duration 
of 16+3s and 75+13s respectively. The average total number of PVC’s 
counted during the first 3 min of reperfusion was 199+30.
3.2.2 Reperfusion-induced 86Rb+ Efflux in Control Hearts
During normal potassium (5.9mM K+) and low potassium (3.2mM K+) 
perfusion, the ere of 86Rb+ remained at a level of approximately 
0.040 min-1 (figure 3.2.2). During CAL, "as might be expected 
following a reduction in the amount of tissue receiving flow, ere 
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Figure 3.2.2
Reperfusion-induced rubidium-86 efflux in control hearts (erc/min).
Hearts were perfused with buffer containing 5.9 mM potassium for 15 min, 
and then with low (3.2 mM) potassium-containing buffer for the remainder 
of the experiment. 10 min after the start of low potassium perfusion, 
the coronary artery of each heart was ligated (CAL) for a further 10 min, 
followed by a 15 min period of reperfusion (REP).
Each point is the mean of 21 experiments. Vertical bars represent the 
standard error of each mean value.
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after reperfusion, 86Rb+ efflux rose sharply, reaching a mean peak 
value of 0.076+0.010 min-1. For the first 3 min of reperfusion, the 
mean area under the efflux curve (which was used as an index of 
total 86Rb+ efflux for this interval) was 0.133+0.023 arbitrary 
units (au). Figure 3.2.3 shows that a good correlation existed 
(r2=0.86, n=21) between peak ere and efflux area for each heart.
The time at which peak ere was attained for each heart did not 
vary. For control and all treated hearts, peak ere occurred during 
the second 30s period of reperfusion.
3.2.3 Reperfusion-induced Lactate Washout and LDH Release
Following reperfusion, there was a substantial release of 86Rb+ 
(section 3.2.2). This may have been caused by myocardial cell 
membrane damage/dysfunction, or simply as a result of the washout 
of accumulated 86Rb+ from the ischaemic area, where coronary flow 
during ischaemia was negligable. A seperate study was therefore 
undertaken to measure lactate and LDH in coronary effluent. Lactate 
is only produced during ischaemia and accumulates in the ischaemic 
zone (Neely and Feuvray, 1981) from where it is washed out during 
reperfusion. LDH however, is an intracellular enzyme that is only 
released following cell membrane damage. A comparison of the time 
course of lactate and LDH release with that of 86Rb+ efflux vrould 
therefore provide evidence of a washout or reperfusion-induced 
release of the radioactive ion. Figure 3.2.4 illustrates the 
outcome of this study. As previously seen (section 3.2.2), 86Rb+ 
efflux rose following reperfusion, reaching a mean peak value in 


















The relationship between the 2 parameters used to assess rubidium-86 
efflux in control hearts.
Peak efflux rate coefficient (ere) values are plotted against area 
under the efflux curve during the first 3 min of reperfusion for 
individual hearts.
Least squares linear regression was performed on all data points  ^
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Figure 3.2.4
Lactate and lactate dehydrogenase concentrations and rubidium-86 ere 
in coronary effluent from control hearts.
Reperfusion was initiated at time 0 after a 10 min period of regional 
ischaemia.
Mean and standard errors are shown for lactate O (pmoles/ml/g wet 
weight, n = 6), lactate dehydrogenase # (U/ml, n = 3) and rubidium-86 
ere □ (min~l x 10, n = 6).
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approached a pre-reperfusion level towards the end of the 10 min 
reperfusion period. LDH release followed a similar time course 
profile. From a pre-reperfusion value of 0.28+0.11 U/ml, the 
concentration of LDH rose to a post-reperfusion peak of 0.90+0.07 
U/ml 30s after reperfusion was initiated. At the end of the 10 min 
period, enzyme concentration had declined to 0.44+0.10 U/ml. 
Contrary to both 86Rb+ and LDH profiles, the washout of lactate 
exhibited a more rapid time course. The concentration of lactate 
just before reperfusion was 0.21+0.01 pnoles/ml/g wet weight. 
Following reperfusion, this level had increased to a mean peak 
value of 0.32+0.04 pmoles/ml/g wet weight after only 15s. Lactate 
concentration had fallen below the ischaemic level 45s after 
reperfusion and was only 0.05+0.01 pnoles/ml/g wet weight after 1 
min. These results strongly suggest that the efflux of 86Rb+ 
following coronary artery reperfusion is not solely a passive 
washout response, but that there is a contribution to this effect 
from reperfusion-induced tissue "damage".
3.2.4 Free Radical Generation and a6Rb+ Efflux
Since free radicals may be involved in reperfusion arrhythmogenesis 
(Woodward and Zakaria, 1985) and potassium loss has also been 
implicated (Lubbe et al, 1978), it was important to determine if 
free radicals could cause potassium (86Rb+) loss in'a normal heart. 
In these experiments, superoxide radicals were generated using a 
xanthine/xanthine oxidase system (McCord and Fridovich, 1968). 
Hearts were perfused with xanthine (O.lmM) and a bolus injection of 
0.01ml (0.65 U) xanthine oxidase administered. No significant
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effect on mean 86Rb+ ere was observed during xanthine perfusion 
(figure 3.2.5a). Administration of xanthine oxidase caused a mean 
increase in ere to a peak value of 0.093+0.015 min-1, rendering a 
mean efflux area (for the first 3 min following xanthine oxidase 
addition) of 0.073+0.035 au (n=10). The magnitude of this response 
was reduced when superoxide dismutase (SOD), a superoxide radical 
scavenger, was perfused concomitantly with xanthine (figure 
3.2.5b). Administration of xanthine oxidase under these conditions 
elevated mean 86Rb+ ere to a peak value of only 0.050+0.005 min-1. 
Similarly, the corresponding efflux area was reduced to 0.045+0.017 
au (n=6). No significant effect on ere was brought about by 
perfusion with xanthine plus SOD. The above results provide 
evidence that the efflux of B6Rb+, a radioactive marker for 
potassium, is stimulated by the xanthine/xanthine oxidase system 
probably as a result of superoxide radical generation. Since hearts 
were not ligated in these experiments, the involvement of 86Rb+ 
accumulation and washout in this response was avoided. As 
reperfusion of ligated hearts also evoked a rise in 86Fb+ efflux 
(section 3.2.1), there exists the possibility that reperfusion 
itself leads to the generation of free radicals. However, 
reperfusion of ligated hearts was also accompanied by the 
development of ventricular arrhythmias, a response that was 
conspicuously absent in the above experiments. One explanation for 
this is that xanthine oxidase-induced free radical generation led 
to a global elevation of 86Rb+ efflux rather than an heterogeneous 
distribution of ions. Consequently, 6 hearts were perfused with 
O.lmM xanthine and ligated prior to the administration of xanthine 
oxidase. Ligation was maintained throughout each experiment. Even
Figure 3.2.5:
The effects of free radical generation on 86Rb+ ere in 
isolated rat hearts.
Radicals were generated by the administration of 0.01ml 
(0.65 U) xanthine oxidase (XO) in (a) hearts perfused with 
O.lmM xanthine (XANTH, n=5) or (b) hearts perfused with 
O.lmM xanthine plus SC© (X+SQD, n=6).
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under these conditions however, xanthine oxidase did not evoke 
arrhythmias in any of the hearts. Assuming that heterogeneous 
radical generation leads to an heterogeneous distribution and 
localised elevation of potassium ions, there vrould appear from 
these results to be no relationship between ionic heterogeneity and 
arrhythmogenesis, although careful interpretation of these data is 
required. For example, free radicals, generated in these 
experiments after CAL, would be located in a much larger area of 
heart tissue (compared with reperfusion-generated radicals, which 
would be localised in the ischaemic zone) that is receiving normal 
and redirected coronary flow and that is likely to possess higher 
activities of endogenous free radical scavengers. In addition, the 
generation of free radicals in non-left ventricular and non-septal 
tissue may not be detrimental to normal cardiac 
electrophysiological function. A relationship between potassium 
distribution cannot therefore be resolved from these data, and 





Hie results presented confirm the findings of others (Lubbe et al, 
1978; Vfoodward and Zakaria, 1983; Manning and Hearse, 1984) that 
reperfusion following transient coronary artery occlusion in 
isolated rat hearts leads to the genesis of ventricular 
tachyarrhythmias. Such observations may be extremely relevant to 
the clinical situation, since arrhythmias also arise during 
angioplastic or thrombolytic procedures (Goldberg et al, 1983) and 
have been proposed by some (Corr and Witkowski, 1983) to be the 
underlying cause of sudden cardiac death. Re-entry circuits are 
considered by many (Janse, 1982; Corr and Witkowski, 1983; Manning 
and Hearse, 1984) to be the mechanism by which ventricular 
fibrillation arises and are thought to result from the heterogeneic 
injury or recovery of myocardial tissue (Manning and Hearse, 1984). 
Arrhythmogenesis is undoubtedly a consequence of disturbances of 
ionic homeostasis (Bernier et al, 1986), and the present work has 
demonstrated that reperfusion is accompanied by a substantial 
efflux of 86Rb+ (a radioactive tracer ion for potassium). This does 
not appear to be the result of washout of ions accumulated in the 
ischaemic region, as demonstrated by a comparison with the washout 
time profile of lactate. However, ligation of the left anterior 
descending coronary artery resulted in only a slight reduction of 
06Rb+ ere values (figure 3.2.2). It could be argued that the 
reduction in flow during CAL to an ischaemic area comprising 30-35% 
of the total ventricular wet weight might be expected to reduce 
86Rb+ ere values during this period by a similar magnitude. The 
fact that it did not requires explanation. In the constant flow
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isolated heart model, ligation of the coronary artery will redirect 
flow from the vascular bed served by that artery to the 
non-ischaemic vasculature. This was routinely observed as an 
increase in perfusion pressure (immediately upon ligation) to 
values between 100 and 150 nrriHg. Similar flow (and consequently 
pressure) increases were demonstrated by Zakaria (unpublished 
results) not to cause vascular damage, as indicated by the absence 
of protein loss following ligation. However, the effects of such 
changes on potassium efflux have not been determined, and it is 
possible that elevated vascular pressure increases efflux either by 
mechanically squeezing adjacent tissue or by perfusing capillaries 
that are underperfused during normal flow conditions. Whilst 
pressure-induced increases in potassium efflux remain to be shown, 
it is conceivable that such a phenomenon could compensate for the 
reduced efflux expected during coronary ligation.
The mechanism responsible for the elevation of 86Rb+ efflux has not 
been determined. The observed response may be caused by a reduced 
influx of 86Rb+ resulting from inhibition of the sarcolemmal 
sodium-potassium pump. Further experiments aimed at monitoring 
sodium fluxes during reperfusion simultaneous with measurements of 
86Rb+ efflux would give some indication of sodium-potassium pump 
activity and may elucidate the role of this system in the observed 
effects on 86Rb+ movements. Other mechanisms have been proposed to 
account for the elevation of extracellular potassium concentrations 
in ischaemic myocardium (Gaspardone et al, 1986). Acidosis develops 
rapidly during ischaemia (Hirche et al, 1980) and whilst imposed 
acidosis (increased pC02 of perfusate) has been shown to alter
61
myocardial potassium fluxes (Poole-Wilson and Langer, 1975), these 
changes comprised a net gain of potassium by the myocardium rather 
than a loss. Potassium loss may also be mediated by an increase in 
membrane permeability, and reductions in cellular ATP levels during 
ischaemia could lead to the opening of potassium channels which 
rely on ATP to maintain their "closed" state (Noma, 1983).
Tranum-Jensen and colleagues (1981) measured an increased cellular 
osmolarity in ischaemic cells that has since been implicated by 
Gaspardone et al (1986) as a possible mechanism by which potassium 
is lost. However, the latter group demonstrated an increased uptake 
of potassium in rabbit interventricular septa perfused with 
hyperosmolar solutions which reverted to a net loss of potassium 
when isosmolar perfusion was resumed. The authors suggested that 
the enhanced influx was the result of potassium exchanging with 
sodium that had left the cell to reduce osmolarity. They proposed 
that reperfusion of ischaemic tissue normalises osmolarity, reduces 
potassium influx and produces a net loss of intracellular 
potassium. More importantly, there was no evidence that potassium 
efflux increased when isosmolar perfusate was reintroduced. It 
therefore seems unlikely that changes in the osmolarity of 
ischaemic cells following reperfusion were responsible for the 
large rises in 86Rb+ efflux observed in the present study.
Patch-clamp experiments have shown the existence of ATP-regulated 
'potassium channels in cardiac sarcolenma that are activated when 
intracellular ATP levels fall (Trube and Hescheler, 1984). Whilst 
potassium channel activation during coronary reperfusion has not,
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to the author's knowledge, been investigated, such activation may 
be responsible for the reperfusion-induced elevation of 86Rb+ 
efflux described earlier. Further studies using potassium channel 
blocking drugs under conditions of ischaemia/reperfusion viould 
elucidate whether 06Rb+ efflux elevation is a channel-mediated
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phenomenon. Several studies, more recently those of Bacaner and 
colleagues (1986), have used potassium channel blockade in dog 
hearts in situ to successfully increase the ventricular 
fibrillation threshold (i.e. the lowest current required to induce 
sustained fibrillation). The converse situation (a decrease in 
ventricular fibrillation threshold) was achieved by Logic (1973) by 
the intracoronary infusion of hyperkalaemic solutions in the same 
model. Experiments such as these illustrate the importance of 
cellular potassium ion gradients to the vulnerability of hearts to 
ventricular fibrillation.
In experiments reported earlier, superoxide radical (02-") 
generation with xanthine/xanthine oxidase reproduced the elevation 
of 86Rb+ efflux seen when hearts were reperfused. This effect 
was reduced in the presence of SOD and is abolished (Zakaria, 1985) 
when inactivated (boiled) xanthine oxidase is used. Although these 
results demonstrate the involvement of 0 2 -" in elevating 86Rb+ 
efflux in non-ligated hearts, it would be premature to extrapolate 
this mechanism to the reperfused heart. Whilst O2 •" has been shown 
to inhibit sodium-potassium ATPase (Na+-K+ ATPase) in brain 
capillaries (Lo and Betz, 1986) and rat lung (Das and Neogi, 1984), 
a similar effect was not investigated in the current study.
Furthermore, inhibition of the Na+-K+ pump has only been observed
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after 30 min of regional ischaemia (Kleber, 1983), although there
is no reason to believe that reperfusion-induced events follow
similar mechanisms to those occurring during ischaemia. Clearly
      _  . .
required.
The objectives stated at the beginning of this chapter have 
generally been achieved. Responses of isolated hearts in terms of 
86Rb+ efflux following reperfusion bare a close similarity to those 
obtained by the enzymic generation of 0 2 -', with the exception that 
the latter procedure did not evoke arrhythmias. Reasons for this
anomoly can only at present be speculative. A global generation of
a.
free radicals lacks the heterogeneity expected of regional 
ischaemia and reperfusion, resulting in a situation that does not 
tend to favour re-entry. In addition, a period of oxygen 
deprivation may be a pre-requisite for free radical-mediated damage 
during oxidative stress. This possibility is supported by 
observations of reduced SOD and glutathione peroxidase activities 
during hypoxia (Guamieri et al, 1980) and ischaemia (Julicher et 
al, 1984). It is therefore possible that by simply generating free 
radicals in the absence of any ischaemic insult and under 
non-heterogeneic conditions, myocyte antioxidant defences may not 
be sufficiently overwhelmed to result in perturbations of ionic 
homeostasis of arrhythmogenic proportions.
Finally, despite the circumstantial evidence supporting a 
relationship between reperfusion-induced arrhythmias, 86Rb+ efflux 
and oxygen free radical generation presented here, the need for
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data to reinforce this hypothesis is clearly apparent. An attempt to 




4.1 INTRODUCTION: PUTATIVE ENDOGENOUS FREE RADICAL SYSTEMS AND 
PHARMACOLOGICAL INTERVENTION
Before free radicals can be implicated as arrhythmogenic factors 
during coronary reperfusion, the criterion must be fulfilled that 
inhibition or removal of the source of free radicals reduces the 
severity of rhythm disturbances. Since it has been demonstrated 
(chapter 3) that free radical generation increases the efflux of 
86Rb+, a response also obtained following reperfusion, there is 
some indication that potassium fluxes are involved in 
arrhythmogenesis and may be modified by free radicals. With these 
considerations in mind, it was considered expedient to study the 
effects of pharmacological intervention on several putative 
endogenous free radical generating systems with regard to the 
severity of arrhythmias and the degree of 86Rb+ efflux following 
reperfusion.
Reduced glutathione (GSH) has been shown to protect against 
reperfusion-induced arrhythmias (Woodward and Zakaria, 1985;
Bernier et al, 1986) at concentrations within the normal 
physiological range for heart tissue (Kosower and Kosower, 1978). A 
reduction of the cellular GSH content is detrimental to many 
physiological processes, including intracellular calcium 
sequestration (Jones et al, 1973; Bellomo et al, 1983; Thor et al,
1985), calcium ATPase activity (Nicotera et al, 1985), drug 
metabolism (Grrenius et al, 1984), polyamine biosynthesis 
(Guamieri et al, 1982) and antioxidant inhibition of lipid 
peroxidation (Barsacchi et al, 1984). The importance of GSH in
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protection against myocardial reperfusion damage is implicated by 
many studies which show a reduction of cardiac GSH levels during 
oxidant stress (Guarnieri et al, 1979; Doroshow et al, 1980), 
cardiac reperfusion (Ferrari et al, 1985; Kajiyama et al, 1987) and 
in endothelial cell cultures exposed to H2O2 (Harlan et al, 1984; 
Tsan et al, 1985). One aim of this study was therefore to examine 
the responses of isolated hearts to GSH perfusion in terms of 
rhythm disturbance and 86Rb+ efflux.
Endogenous systems capable of generating oxygen free radicals were 
reviewed in chapter 1, and the role of transition metals in these 
processes was emphasized. The participation of iron in free radical 
generating systems is often studied by removing free iron with 
chelating agents (Halliwell and Gutteridge, 1985). The most 
commonly used agent for chelating metals is ethylenediamine- 
tetraacetic acid (EDTA). However, for the removal of iron from free 
radical reactions, EDTA is inadequate because the resultant 
Fe3+-EDTA complex can still be reduced by 02-" (Butler and 
Halliwell, 1982). EDTA is also a strong chelator of calcium and may 
therefore exert other non-specific effects. More commonly used is 
desferrioxamine, an iron chelator extracted from the bacterium 
Streptomyces pilosus. Desf errioxamine is a linear molecule 
containing three N-0 and three C=0 groups. One molecule binds one 
Fe3+ ion by bending round the six oxygen ligands to form an 
Fe3+-desferrioxamine complex. The Fe3+ ions are bound tightly so 
that they cannot be reduced by 02-". Desf errioxamine is relatively 
specific for Fe3+ ions (although it will bind Al3+ ions also) and 
is commonly used in the treatment of beta-thalassaemia and other
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diseases that lead to iron overload (Halliwell and Gutteridge,
1985). Desf errioxamine was therefore employed in the present study 
to investigate the effects of iron chelation on reperfusion 
arrhythmias and 86Rb+ efflux in isolated rat hearts.
The elevated myocardial concentration of noradrenaline during 
ischaemia and reperfusion (section 1.5.3) has been implicated as an 
arrhythmogenic factor (Schomig et al, 1984). Woodward and Manning 
(1987) have suggested that "the lack of a consistent picture 
regarding the antiarrhythmic properties of alpha- and beta-receptor 
antagonists points to alternative mechanisms by which noradrenaline 
may be arrhythmogenic". One possibility is the generation of free 
radicals resulting from catecholamine autoxidation. Indeed, Zakaria
(1985) was able to abolish the reperfusion-induced reduction of 
ferricytochrcme c (an assay for 0 2 -“) by depleting rats of 
catecholamines using 6-hydroxydopamine (6-OHDA). This method was 
therefore employed in the present study to examine the effects of 
catecholamine depletion on the incidence of arrhythmias and the 
efflux of 86Rb+ following reperfusion of isolated hearts.
The involvement of xanthine oxidase in free radical-mediated 
reperfusion damage has been extensively studied in the intestine 
(Parks and Granger, 1983; Roy and McCord, 1983; Granger et al,
1986). Such studies have provided a basis for investigations of the 
enzyme's involvement in myocardial damage, and this is considered 
in detail in chapters 1 and 6. However, an aim of the work 
presented in this chapter was to assess the contribution of 
xanthine oxidase-derived free radicals to reperfusion-induced
arrhythmias and 86Rb+ efflux. For this purpose, the xanthine 
oxidase inhibitors allopurinol and oxypurinol were employed. 
Allopurinol is an antihyperuricaemic agent, but has also been shown 
experimentally to reduce myocardial infarct size (Akizuki et al, 
1985) and attenuate free radical-induced increases of vascular 
permeability (Korthuis et al, 1985). Whilst allopurinol's mode of 
action in these pathological conditions is uncertain, the drug has 
been demonstrated to dilate coronary collateral vessels (Arnold et 
al, 1980) and preserve tissue levels of high energy adenine 
nucleotides (De Wall et al, 1971). Allopurinol1s inhibitory action 
on xanthine oxidase has been elucidated. Spector and co-vorkers
(1986) described allopurinol as a "suicide" substrate for the 
enzyme. It becomes oxidised to oxypurinol which binds tightly to 
xanthine oxidase and competitively inhibits the enzyme (overall 
inhibition constant = 85nM-100nM). In 1984, Manning and colleagues 
demonstrated a reduction of the incidence of reperfusion-induced 
ventricular fibrillation in in situ hearts of rats treated with 
20mg/kg allopurinol. In isolated rat hearts, Zakaria (1985) was 
unable to show a significant reduction of arrhythmias following 
reperfusion when allopurinol (O.lmM) was perfused through hearts 5 
min before CAL. It is possible that in the latter experiments, 
insufficient time was allowed for the conversion of allopurinol to 
oxypurinol (the active inhibitor of xanthine oxidase), although the 
time required for this process has not been reported. On the basis 
of these findings, it seemed important to determine whether the 
antiarrhythmic effects of allopurinol pre-treatment could be 
reproduced by perfusion of oxypurinol through hearts prior to 
CAL/reperfusion.
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Since reperfusion arrhythmias can be reduced in isolated hearts by 
SOD (Woodward and Zakaria, 1985), implicating a role for 02*" in 
this response, it is proposed that inhibition of endogenous SOD 
should exacerbate the incidence of arrhythmias on reperfusion. A 
method for the inhibition of SOD, using the powerful copper 
chelating agent diethyldithiocarbamate (DDC), is available 
(Heikkila et al, 1976) and has been shown to reduce cardiac SOD 
activity in rats by 93% at a dose of 1.2g/kg ip (Rossoni Caldarera 
et al, 1982). The activity of DDC is ascribed to its ability to 
chelate the copper of Cu-Zn SOD, since Heikkila and colleagues were 
able to restore SOD activity by the addition of copper sulphate 
solution. The Cu2+ ions were thought to compete with the enzymic 
copper for DDC, thus removing DDC and restoring enzyme activity.
DDC may also be active on Mn SOD, since Rossoni Caldarera et al 
(1982) demonstrated a reduction of respiratory function in 
mitochondria extracted from the hearts of rats pre-treared with 
DDC. The authors attributed the reduced mitochondrial function to 
the accumulation and damaging effects of 0 2 *“, which had not been 
neutralised by the inhibited SOD. However, their assumption that Mn 
SOD was the inhibited enzyme may have been premature. Steinman 
(1982) has demonstrated that Cu-Zn SOD is also present between the 
inner and outer mitochondrial membranes, and it is possible that it 
was this form of the enzyme that was inhibited by Rossoni 
Caldarera*s group. DDC was used in the present study to inhibit SOD 
activity and examine the effects of this inhibition on reperfusion 
arrhythmias and 86Rb+ efflux. Enzyme inhibition was confirmed in a 
cell-free system by comparing the reduction of 0 2 -~ production 
(indicated by the reduction of ferricytochrome c) by SOD in the
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presence and absence of DDC.
The final objective to be described in this chapter was to assess 
the importance of oxygen on the parameters studied. Hearse et al 
(1973) demonstrated that reoxygenation of hypoxically perfused 
hearts results in myocardial damage characterised by the release of 
intracellular enzymes. Zakaria (1985) extended this study by 
reperfusing regionally ischaemic isolated rat hearts with anoxic 
buffer and was able to show a reduced incidence of reperfusion 
arrhythmias compared with hearts reperfused with oxygenated buffer. 
These results contradict the findings of Petropoulos and Meijne 
(1964) who reported that reperfusion of ischaemic myocardium with 
venous blood or anoxic buffer did not influence the incidence of 
ventricular fibrillation during reperfusion. Experiments were 
therefore performed in an attempt to resolve the equivocalities of 
these studies, the results of which are described below.
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4.2 RESULTS: GLUTATHIONE
Three concentrations of the free radical scavenger reduced 
glutathione (GSH), O.OlmM, O.lOmM and lmM, were perfused through 
isolated hearts. Effects on arrhythmias, 06Rb+ efflux and cardiac 
haemodynamics were investigated and compared with those of the 
control group.
4.2.1 Arrhythmias
All concentrations of GSH reduced the incidences of VT and VF 
following reperfusion (figure 4.2.1). From a control incidence of 
86%, VT was reduced to 60%, 58% and 78% by O.OlmM, O.lOmM and lmM 
GSH respectively. Statistical significance was only attained with 
O.lOmM GSH. The control incidence of VT (72%) was reduced to 60% by 
O.OlmM GSH, 42% by O.lOmM GSH and 48% by lmM GSH; the last tvro 
reductions were significant when compared with the control group.
The effects of GSH on the onset and duration of arrhythmias are 
shown in table 4.2.1. The only significant change was a delay in 
the onset of VT in the presence of lmM GSH. Compared to the control 
value (6+ls), VT onset was delayed until 15+6s after reperfusion. 
The number of PVC's that occurred during the first 3 min of 
reperfusion was unaffected by all concentrations of GSH.
4.2.2 86Kb+ Efflux






























The percentage incidence of VT (open bars) and VF (shaded bars), 
following reperfusion, in control hearts (n = 43) and hearts perfused 
with glutathione (GSH).
0.01 mM GSH, n = 10; 0.10 mM GSH, n = 12; 1 mM GSH, n = 27.











CONTROL 43 37 6+ 1 16± 3 31 13± 2 75±13 199±30
GSH 10-5M 10 6 3+ 1 33+ 8 6 11+ 2 25+10 166+80
10-4M 12 7 11+ 4 13+ 4 5 25+11 49+32 111+38
10-3M 27 21 15+ 6* 16+ 5 13 19+ 4 75+15 121+25
Table 4.2.1:
The onset and duration of VT and VF and the number of PVC's during the 
first 3 min of reperfusion in control and glutathione-treated (GSH) 
hearts.
* p<0.05 compared with the control value.
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is shown in figure 4.2.2. Mean peak efflux and mean efflux area in 
control hearts (0.076+0.010 min-1 and 0.133+0.023 au respectively) 
were significantly reduced only by lmM GSH. In this group, mean 
peak 86Rb+ efflux was 0.044+0.002 min-1 and mean efflux area fell 
to a value of 0.039+0.007 au.
4.2.3 GSH-related Haemodynamic Changes
Changes in heart rate (HR), developed tension (dT) and perfusion 
pressure (PP) following perfusion with O.OlmM GSH, O.lOmM GSH and 
lmM GSH are presented in figure 4.2.3. The data shown represent the 
differences between pre- and post-drug values. HR was significantly 
reduced by 10+4 bpm and 12+3 bpm with O.OlmM GSH and O.lOmM GSH 
respectively. Significant reductions of dT were observed with 
O.lOmM GSH (0.61±0.36g) and lmM GSH (0.91±0.28g). GSH also 
exhibited a concentration-dependent vasodilator action. O.OlmM, 
O.lOmM and lmM concentrations caused PP to fall by 8+2mriHg,
20+3niriHg and 29+2mriHg respectively.
4.3 RESULTS: OTHER PHARMACOLOGICAL INTERVENTIONS
The relationship between arrhythmogenesis and potassium loss was 
again studied using interventions thought to affect free radical 
generation. The drugs used were desf errioxamine, 6-hydroxydopamine 
(6-OHDA), allopurinol, oxypurinol and diethyldithiocarbamate (DDC). 
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Figure 4.2.2
Reperfusion-induced rubidium-86 efflux in control (n = 21) and 
glutathione (GSH)-perfused hearts.
Vertical bars represent mean peak ere (min ^; open bars) and mean efflux 
area (au; shaded bars), with corresponding standard errors (vertical 
lines), for the first 3 min of reperfusion.
0.01 mM GSH, n = 6; 0.10 mM GSH, n = 5; 1 mM GSH, n = 21.

















Haemodynamic responses of isolated rat hearts to 
glutathione (GSH).
Results are expressed as the mean and standard error 
of the change following GSH perfusion.
*p<0.05 compared with the pre-treatment value.
Mean pre-treatment values: HR: 256+3 bpm (n=61)
dT: 8.3±0.lg (n=61)




At concentrations of O.lmM and lmM, desf errioxamine did not 
significantly affect the incidences of VT or VF (figure 4.3.1). 
Similarly, the onset and duration of arrhythmias and the number of 
FVC's observed following reperfusion were not statistically 
different from control values (table 4.3.1).
(b) 6-OHDA:
To investigate the possible arrhythmogenic role of free radicals 
generated by the autoxidation of myocardial noradrenaline, rats 
were pre-treated with 6-OHDA (60mg/kg iv) 24 hours before hearts 
were excised. 6-OHDA destroys sympathetic nerve terminals causing 
the release, oxidation and subsequent depletion of catecholamines. 
Successful administration of 6-OHDA was apparent from the 
appearance of treated animals, namely pilo-erection, peripheral 
cyanosis and lethargy. However, depletion of catecholamines was 
confirmed pharmacologically in hearts prior to each experiment. A 
bolus administration of tyramine (0.1ml, O.lmM), an indirect 
sympathomimetic drug that displaces noradrenaline from 
intracellular stores, was without effect in all 6-GHDA-treated 
hearts, indicating successful depletion. Non-treated control 
hearts, when administered the same dose of tyr amine, exhibited 

























The percentage incidence of VT (open bars) and VF (shaded 
bars) following reperfusion in isolated rat hearts.
CONTROL (n=43); DESF, desf errioxamine (O.lmM n=ll, lmMn=10); 
OXYP, oxypurinol (lpM n=13); 6-OHDA, 6-hydroxydopamine 
(60mg/kg n=12); ANOXCAL, hypoxically perfused from 2 min 
before CAL (n=12); ANOXREP, hypoxically perfused from 2 min 
before reperfusion (n=12).
* p<0.05 compared with the control group.
VT VF
_________________  PVC's
n n ONSET DURATION n ONSET DURATION
(sec) (sec) (sec) (sec)
CONTROL 43 37 6± 1 16± 3 31 13± 2 75±13 199±30
DESF:
10-4M 11 10 5+ 1 9± 1 9 12+ 1 106+27 72+25
10" 3H 10 8 3± 1 12± 3 8 11± 2 96+28 105+14
OXYP: 
10-6M 13 12 2± 1* 17± 5 11 13± 3 101±21 195±58
6-OHDA:
60mg/kg 12 8 22+14* 14± 4 6 13± 3 44±28 138±44
ANOXCAL 12 11 13+ 8* 23+ 4* 8 27+ 8* 153+ 8* 321+54*
ANOXREP 12 12 2± 1 12± 2 8 22± 9 143±16 211±42*
SALINE 10 9 3+ 1 6+ 1 9 9+ 1 50+23 97+26
ALLO 11 9 4± 1 9± 3 2 7± 2 173± 2* 123±44
SALINE 11 7 2+ 1 13± 2 6 11+ 2 8+ 2 136+31
DDC 12 12 5± 3 11± 3 6 9± 2 19± 4* 161±34
Table 4.3.1:
The onset and duration of VT and VF and the number of PVC's during the 
first 3 min of reperfusion in control and drug- treated hearts.
DESF, desf errioxamine; OXYP, oxypurinol; 6-OHDA, 6-hydroxydppamine; 
ANOXCAL, hypoxically perfused from 2 min before CAL; ANOXREP, hypoxically 
perfused from 2 min before reperfusion; ALLO, allopurinol (20mg/kg); DDC, 
diethyldithiocarbamate (1.5g/kg).
* p<0.05 compared with the appropriate control value.
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Although the incidences of VT and VF in hearts from treated animals 
were reduced (67% and 50% respectively), these changes were not 
statistically significant (figure 4.3.1). The onset of VT was 
significantly delayed however, from the control mean value of 6+ls 
to 22+14s. None of the other parameters was significantly affected 
(table 4.3.1).
(c) Hypoxic perfusion:
The effect of oxygen deprivation on arrhythmogenesis and 86Rb+ 
efflux was tested by perfusing hearts with buffer rendered hypoxic 
by gassing with 95% N2/5% CO2 . Hypoxic perfusion was initiated 2 
min before CAL (ANOXCAL) and, in a separate series of experiments,
2 min before the onset of reperfusion (ANOXREP). Figure 4.3.1 
illustrates the arrhythmic responses of hearts under these 
conditions.
The incidences of VT and VF were not significantly affected by 
either protocol. However, when hypoxia was induced before CAL, both 
the onset of VT (13+8s) and VF (27+8s) were significantly delayed 
when compared to the control values (6+ls and 13±2s respectively; 
table 4.3.1). The total duration of each type of arrhythmic episode 
was prolonged (23+4s for VT and 153+8s for VF). The number of PVC's 
was also increased to 321+54. No significant changes to onset times 
and durations of VT or VF were observed when hypoxic perfusion 
began 2 min prior to reperfusion, although the number of FVC's was 
again increased, this time to 211+42.
It was therefore apparent that hypoxia did not protect against
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ventricular tachyarrhythmias, but rather delayed and prolonged 
arrhythmic episodes and increased the number of spontaneous PVC's.
(d) Allopurinol and oxypurinol:
Rats were pre-treated with allopurinol (2Qmg/kg ip 48hours, iv 15 
min; a dose shown by Manning et al (1984) to reduce reperfusion 
arrhythmias in anaesthetised, open-chest rat heart preparations) 
dissolved in 1M NaOH and diluted with perfusion buffer (final pH = 
8). Control rats were treated identically with an equivalent volume 
of 0.9% (w:v) saline (pH 8).
Figure 4.3.2 shows that the control incidences of VT and VF were 
both 90%. Hearts from allopurinol-treated animals exhibited a 
significant reduction of VF incidence to a value of 18%. The 
incidence of VT was not significantly altered. Despite this marked 
antifibrillatory effect, the duration of VF was more than triple 
that of the control group (173+2s compared with 50+23s; table 
4.3.1).
Inhibition of xanthine oxidase by allopurinol is mediated by its 
oxidised metabolite oxypurinol (Spector et al, 1986). Consequently, 
the effect of oxypurinol on arrhythmogenesis was investigated by 
perfusing the drug through hearts. A concentration of IjjM was used, 
since Spector and colleagues (1986) demonstrated an overall 
inhibition constant, Ki, for oxypurinol of 85-100nM. In view of the 
above allopurinol data, the lack of protection against arrhythmias 
afforded by oxypurinol was surprising (figure 4.3.1). Neither the 
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Figure 4.3.2:
The percentage incidence of VT (open bars) and VF (shaded 
bars) following reperfusion in hearts from rats pre­
treated with allopurinol (ALIO, 20mg/kg)/ diethyldithio- 
carbamate (DDC, 1.5g/kg), or equivalent volumes of saline 
(0.9% w:v).
Hearts from rats pre-treated with DDC were perfused with 
buffer containing 5. 9mM potassium to reduce the control 
incidence of arrhythmias (see section 4.3.1(e)).
* p<0.05 compared with the appropriate saline control group.
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values. Furthermore, episodes of VT occurred earlier (2+ls) 
following oxypurinol perfusion than in the control group (6+ls).
The discrepancy between the antiarrhythmic action of allopurinol 
and a failure to protect against arrhythmias with oxypurinol may be 
the result of a direct antiarrhythmic effect of the former drug 
rather than an anti-free radical mechanism. Ideally, an 
investigation of the electro-physiological effects of allopurinol 
on the cardiac action potential would have demonstrated any such 
direct action. However, since this was not possible in our 
laboratory, an attempt to reveal any class I antiarrhythmic 
property was made by inducing VF in hearts using an 
11 arrhythmogenic1' perfusion fluid of low potassium, zero magnesium 
and high calcium concentrations (see section 2.1.3). In control 
hearts, VF developed 220±lls (n=6) after initiation of 
arrhythmogenic perfusion. In hearts excised from rats pre-treated 
with 20mg/kg allopurinol as previously described, the onset time of 
VF was 191+17s (n=6). There was, therefore, no evidence of a class 
I action, although a more detailed investigation is recommended.
(e) Diethyldithiocarbamate (DDC):
Evidence has been reported (Woodward and Zakaria, 1985; Bernier et 
al, 1986) which implicates an arrhythmogenic role for 02*“, since 
SOD reduced the incidence of reperfusion arrhythmias in both of 
these studies. Consequently, inhibition of endogenous cardiac SOD 
would be expected to exacerbate arrhythmias initiated by 
02-"-related mechanisms. This supposition was tested using hearts 
from rats pre-treated with 1.5g/kg DDC (ip 1 hour), a drug
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previously shown by Heikkila and co-vrorkers (1976) to inhibit SOD 
at this concentration by 81% 1 hour after administration to mice. 
Hearts were perfused throughout experiments with buffer containing 
5.9mM potassium. The low incidence of reperfusion arrhythmias 
obtained with this concentration of potassium facilitated the 
observation of any detrimental (proarrhythmic) effects of DDC. The 
results of these experiments are illustrated in figure 4.3.2.
In control animals, the incidences of VT and VF were 64% and 55% 
respectively. All hearts from DDC-treated rats underwent episodes 
of VT, representing a statistically significant increase. The 
incidence of VF (50%) was statistically similar to the control 
value, although the duration of VF was longer (19+4s) than that of 
the control group (8+2s).
To verify the inhibitory action of DDC on SOD, the ferricytochrome 
c reduction assay was employed (McCord and Fridovich, 1968). Figure
4.3.3 shows the effect of 4 concentrations of SOD (12.5mU, 25.0mU, 
37.5mU and 50.0mU) on the rate of ferricytochrome c reduction 
induced by 2mU of xanthine oxidase in the presence of 50pM 
xanthine. These experiments were carried out in a cell-free system 
of 1ml final volume (see section 2.4.2). When administered alone, 
xanthine oxidase reduced ferricytochrome c at a rate of 0.070+0.001 
absorbance units/min. In the presence of the above concentrations 
of SOD, the reduction rate was lowered to 0.045+0, 0.031+0.009, 
0.035+0.004 and 0.024+0.006 absorbance units/min respectively. The 
inclusion of O.OlmM and O.lOmM DDC (concentrations calculated from 
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The rate of ferricytochrome c reduction (absorbance units/min) induced 
by 2 mU xanthine oxidase (X0, n=3).
Experiments were repeated in the presence of 4 doses of superoxide 
dismutase (SOD) aloneHland in combination with 0.01 mM diethyldithio- 
carbamate (DDC) or 0*1 DDC ||| (n = 2 per group).
The mean and standard error of each reduction rate are shown.










the action of SOD in a concentration-dependent manner. 0. ImM DDC 
abolished the effects of SOD at all concentrations. With O.OlmM 
DDC, complete inhibition was only observed at the lowest SOD 
concentration (12.5mU). These results demonstrate that the 
superoxide radical scavenger, SOD, is inhibited by DDC in vitro.
4.3.2 86Eb+ Efflux
(a) Desf errioxamine:
Neither concentration of desf errioxamine (O.lmM and ImM) 
significantly altered mean peak 86Rb+ efflux (0.062+0.014 min-1 and 
0.057+0.006 min-1 respectively) or mean efflux area (0.094+0.022 au 
and 0.096+0.030 au respectively) compared with the control values 
(0.076+0.010 min-1 and 0.133+0.023 au; figure 4.3.4).
(b) 6-OHDA:
Significant reductions of 86Rb+ efflux were observed in the hearts 
of 6-OHDA-treated rats, both in terms of mean peak ere (0.044+0.003 
min"1) and mean efflux area (0.052+0.014 au). These changes occurred 
despite an insignificant reduction of VF incidence in these hearts 
(section 4.3.1(b)).
(c) Hypoxic perfusion:
86Rb+ efflux in hearts rendered hypoxic 2 min prior to CAL was 
unchanged (0.075+0.014 min-1 and 0.147+0.058 au) compared with that 
of the control group (figure 4.3.4). However, hearts subjected to 
hypoxic perfusion 2 min before reperfusion exhibited significant 



















Reperfusion-induced a6Rb+ efflux in control (n=21) and 
drug-treated hearts.
Mean peak ere (min-1, open bars) and mean efflux area (au, 
shaded bars) are shown with corresponding standard errors 
for the first 3 min of reperfusion.
DESF, desf errioxamine (O.lmM and ImM, n=6 per group); OXYP, 
oxypurinol (lpMn=7); 6-OHDA, 6-hydroxydopamine (60mg/ml 
n=6); ANOXCAL, hypoxically perfused from 2 min before CAL 
(n=5); ANOXREP, hypoxically perfused from 2 min before 
reperfusion (n=6).
* p<0.05 compared with the control group.
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control value of 0.076+0.010 min-1 to 0.113+0.021 min-1. Mean 
efflux area in the control group was 0.133+0.023 au; the 
corresponding value for the ANOXREP group was 0.276+0.032 au. The 
ANOXCAL data show that although VF duration was significantly 
increased, there was no corresponding increase in 86Rb+ efflux. 
86Rb+ efflux time profiles for both protocols (figure 4.3.5) reveal 
that hypoxic perfusion, when initiated 2 min before CAL (figure 
4.3.5(a)), transiently raised 86Rb+ ere. This effect was maximal 
2-4 min after the start of hypoxic perfusion, but was probably not 
of sufficient magnitude to add significantly to the 
post-reperfusion response of the ANOXREP group (figure 4.3.5(b)).
It is likely, therefore, that other mechanisms were responsible for 
the elevation of reperfusion-induced 86Rb+ efflux in hypoxic 
hearts. This possibility is discussed in section 4.4.
(d) Allopurinol and oxypurinol:
The substantial reduction of the incidence of VF in hearts from 
allopurinol-treated rats (section 4.3.1(d)) was not associated with 
a significant change in reperfusion-induced 86Rb+ efflux (figure 
4.3.6). The absence of an effect on 86Rb+ efflux suggests a 
dissociation between this parameter and the antiarrhythmic action 
of allopurinol. However, the lack of protection against arrhythmias 
afforded by oxypurinol, and the drug's ineffectiveness at reducing 
86Rb+ efflux (figure 4.3.4), are as vrould be predicted if a 
relationship between 86Rb+ efflux and arrhythmogenicity exists. 
Furthermore, these negative responses suggest that xanthine oxidase 
endogenous to rat hearts, should it be present at all, is not an 
important factor in reperfusion arrhythmias in this model.
Figure 4.3.5:
86Rb+ ere values (min-1) in hearts perfused with hypoxic 
perfusion fluid (a) 2 min before coronary artery ligation 
(CAL, n=5) or (b) 2 min before reperfusion (REP, n=6).
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Reperfusion-induced rubidium-86 efflux in hearts from rats pre-treated 
with allopurinol (20 mg/kg, ip 48 hours, iv 15 min, n = 8) and 
diethyldithiocarbamate (DDC, 1.5 g/kg, ip 1 hour, n = 5).
In control groups, 0.9 % w:v saline was administered in place of the 
drug (allopurinol control, n = 10; DDC control, n = 5). Hearts in DDC 
control and test groups were perfused with buffer containing 5.9 mM 
potassium (section 4.3.1 (e)).
Vertical bars represent mean peak ere (min ^, open bars) and mean efflux 
area (au, shaded bars), with corresponding standard errors (vertical 
lines), for the first 3 min of reperfusion.
*p^0.05 compared with the appropriate control group.
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(e) Diethyldithiocarbamate (DDC):
Hearts from DDC-treated rats did not exhibit significant changes in 
either mean peak ere or mean efflux area (figure 4.3.6), despite 
enduring an increased incidence of VT. The detrimental effect of 
SOD-inhibition by DDC, whilst increasing the duration of VF, was 
apparent from this observation alone. Should there be a 
relationship between the occurrence of arrhythmias and an elevated 
efflux of 86Eb+, it voild appear from these results that VT is not 
a major cause or consequence of the latter response. In addition, 
these data imply that 0 2 -" or 0 2 - "-derived radicals are involved in 
the genesis of VT, but are not major determinants of VF, although 




Perfusion of hearts with desf errioxamine (O.lmM and ImM) did not 
significantly alter HR or dT. However, both concentrations reduced 
PP (figure 4.3.7), although these responses were not 
concentration-dependent. O.OlmM desf errioxamine lowered PP by 
18+2rrmHg, representing a statistically significant change. This 
vasodilator action did not reduce the incidence of arrhythmias 
(section 4.3.1(a)) or alter the reperfusion-induced efflux of 06Rb+ 
(section 4.3.2(a)). There was, therefore, no evidence of coronary 
stecil protection in these experiments.
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(b) Oxypurinol:
ljjM oxypurinol significantly reduced dT by 1.02±0.26g and induced a 
fall in PP of 13+4rrmHg (figure 4.3.7). As with desf errioxamine, the 
vasodilator response to oxypurinol was not associated with a 
reduction in arrhythmias or the magnitude of 86Rb+ efflux.
(c) Hypoxic perfusion:
The main haemodynamic response of hearts to hypoxia was a reduction 
of PP (figure 4.3.7). Early induction of hypoxia (ANOXCAL) resulted 
in a substantial, significant fall in PP of 23+4mmHg. This effect 
was achieved 3-4 min after the initiation of hypoxic perfusion.
When induced 2 min before reperfusion (ANOXREP), hypoxia caused PP 
to fall by 14+2nmHg. In the ANOXCAL group, the reduction of dT 
(l±0.5g) achieved statistical significance.
The vasodilator response of hearts to hypoxia was again not 
associated with protection against arrhythmias or accompanied by a 
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Figure 4.3.7:
Haemodynamic responses of isolated rat hearts to 
desf errioxamine (DESF; O.lmM and lmM,n=10), oxypurinol 
(OXYP; lpM, n=13) and hypoxic perfusion from 2 min before 
CAL (ANOXCAL,n=12) or 2 min before reperfusion (ANOXREP,n=9)
Results are expressed as the mean and standard error of the 
change following treatment.
* p<0.05 compared with the pre-treatment value.
For pre-treatment values, see figure 4.2.3.
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4.4 DISCUSSION
Protection against reperfusion-induced arrhythmias was afforded by 
GSH in accordance with similar observations by other groups 
(Wbodward and Zakaria, 1985; Bernier et al, 1986). The 
antiarrhythmic action of GSH was not concentration-dependent, and 
this contrasts with the results of Woodward and Zakaria (1985) who 
achieved a greater reduction in the incidence of VF with increasing 
concentrations of GSH. However, Bernier and colleagues (1986) 
demonstrated an inverse relationship between GSH concentration and 
the incidence of fibrillation. The reason for these equivocalities 
is not readily apparent although the vasodilator component observed 
in the present study may be a contributory factor. Whilst Bernier 
and co-workers (1986) obtained a GSH-mediated increase in coronary 
flow of approximately 50% during ischaemia, this effect was not 
discussed. The ability of the GSH/GSH peroxidase system to 
"scavenge" H2O2 and reduce the formation of OH- is now firmly 
acknowledged, but the contribution of this system to the 
antiarrhythmic action of GSH in isolated hearts has not been 
quantified. It is therefore conceivable that GSH exerts multiple 
effects that act synergistically to reduce the vulnerability of 
hearts to reperfusion arrhythmias.
The results presented previously show that, whilst the maximum 
antiarrhythmic protection of GSH was achieved at a concentration of 
O.lmM, a reduction of the reperfusion-induced rise in 86Rb+ efflux 
was only observed with ImM GSH. This complicates the direct 
correlation between arrhythmia incidence and 86Rb+ efflux elevation
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in this model. The greatest dilator action of GSH was also obtained 
with a ImM concentration and it may be prudent to suggest an 
association between dilation and the degree of 86Hb+ efflux. This 
possibility was investigated further and is detailed in chapter 5.
An important consideration with regard to GSH's anti-free radical 
action in the model studied is a reliance upon the delivery to the 
heart of reduced GSH. Any molecule or compound that contains free 
sulphydryl groups is vulnerable to oxidation to the disulphide 
(Kosower and Kosower, 1978). The susceptibility of sulphydryl 
agents to oxidation varies according to the steric stability 
afforded by adjacent groups on the molecule (B.Swann; personal 
communication). Gassing solutions of GSH with 95% 02/5% CO2 may 
therefore oxidise GSH to GSSG, although GSH has been reported to 
react sluggishly with O2 (Meister and Anderson, 1983). However, it 
was considered important to determine whether GSH oxidation had 
occurred during gassing in the experiments described earlier. AH NMR 
analysis of freshly prepared solutions of GSH and GSSG (before and 
after a 1 hour period of gassing) confirmed that little, if any,
GSH oxidation had taken place (S.Branch; personal communication).
Ferrous (Fe2 + ) and ferric (Fe3 + ) ions are important catalysts in 
free radical generating reactions in aqueous solutions (Halliwell 
and Gutteridge, 1984). Although tissue iron levels have been shown 
to rise in the hearts of dogs during experimental coronary artery 
' occlusion (Aust and White, 1985), and perfusion of isolated rat 
hearts with the iron chelator desf errioxamine reduced the incidence 
of reperfusion arrhythmias in the study by Bernier et al (1986), a
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direct correlation between cardiac iron levels and reperfusion 
arrhythmogenesis has not been demonstrated. This may be a 
consequence of the lack of specificity of iron assay systems such 
as that employed and reported by Aust and White (1985), which did 
not differentiate between the various iron chelates present in 
tissues. Ferritin-bound iron constitutes the largest single pool of 
iron in cells (Aust and White, 1985), and this is sequestered in an 
inert form. Despite the latter authors' assertion that iron bound 
to ferritin may be released to participate in oxidation reactions 
such as those involved in free radical generation, the time-course 
and extent to which this occurs has again not been demonstrated in 
ischaemic hearts. The results of the present study, which 
demonstrated a lack of antiarrhythmic protection and a failure to 
reduce 86Rb+ efflux with desferrioxamine, suggest that iron does 
not participate in the generation of arrV^WMvcvS during early 
reperfusion, and this finding concurs with the results of Woodward 
and Zakaria (1985). Alternatively, it is possible that 
desferrioxamine does not chelate iron sufficiently to prevent its 
catalytic role in free radical production. This seems unlikely, 
since desferrioxamine has proved effective in ameliorating the 
symptoms of other disease states associated with iron overload 
(Halliwell and Gutteridge, 1985). A final possible explanation may 
be that iron-catalysed free radical generating reactions only 
contribute to the pathogenesis of reperfusion damage in the heart 
at a later stage. Such reactions are thought to be the underlying 
cause of lipid peroxidation, a‘degradative process manifested as 
irreversible myocardial damage and ultimately myocardial infarction 
(Meerson et al, 1982). Aust and White (1985) postulated that the
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initial release of tissue iron facilitates the release of 
additional iron which participates in processes of tissue 
destruction. It is the authors' belief that desf errioxamine cannot 
prevent early iron release but can alleviate subsequent 
iron-induced tissue damage. In the light of the current results, 
further wark is clearly required to elucidate the role of iron in 
putative free radical-mediated reactions resulting in 
arrhythmogenesis. This vrork must entail specific measurements of 
tissue iron over a longer time-course than that employed in the 
present experiments. The discrepency concerning the antiarrhythmic 
action of desferrioxamine demonstrated by Bernier et al (1986) 
cannot, as yet, be explained, although detailed comparisons of 
experimental conditions and the carmercial reagents employed may 
expose the critical variant. The cause of this disparity may, in 
itself, help to elucidate the arrhythmogenic mechanisms of 
reperfusion.
The degree to which myocardial catecholamine depletion protects 
against reperfusion arrhythmogenesis is not clear from experiments 
using 6-GHDA-treated animals. The lower incidence of arrhythmias 
observed in this group did not significantly differ from control 
values, although the onset of VT was delayed. The 
reperfusion-induced rise in 86Rb+ efflux was significantly 
attenuated however. The reduction of arrhythmogenesis in this 
group, despite its lack of statistical validity, implies that 
catecholamines are involved to some extent in this response. 
Whether the production of free radicals is associated with this 
action cannot be determined from the data described, although
86
Woodward and Zakaria have demonstrated significantly lower free 
radical production in hearts from 6-QHDA-treated rats (unpublished 
data, cited by Woodward and Manning, 1987). Sheridan et al (1980) 
were also able to reduce the incidence of reperfusion arrhythmias 
in cats following 6-GHDA treatment, but ascribed this effect to a 
reduction of adrenergic receptor stimulation. The protective action 
of catecholamine depletion may also be of metabolic origin. 
Daugherty (1981) observed a significantly higher myocardial 
glycogen level in hearts from 6-OHDA-treated rats subjected to 
coronary ligation. Preservation of cardiac high energy phosphates 
through maintained or elevated levels of substrates such as 
glycogen is undoubtedly of importance in maintaining active 
systems, including those resposnible for cellular ion homeostasis. 
The sustained control of 86Rb+ efflux following reperfusion in 
catecholamine depleted hearts may therefore be closely related to 
the energy status of the myocardium, although further studies are 
required to substantiate this hypothesis.
Myocardial ischaemia has been described as a "priming" period for 
the production of oxygen radicals upon reperfusion. McCord (1984) 
has suggested that ischaemia-induced changes result in xanthine 
oxidase-derived radical generation (see below). The availability of 
oxygen is another, seemingly obvious, prerequisite for 
reperfusion-induced oxygen radical production. However, reducing 
this availability, by perfusing hearts with hypoxic buffer 2 min 
prior to reperfusion, did not afford any protection to hearts in 
terms of arrhythmias or a6Rb+ efflux. When hypoxic perfusion was 
initiated 2 min prior to the ischaemic interval, some
87
antiarrhythmic protection was apparent; although the incidences of 
arrhythmias were unchanged, there was a tendancy for arrhythmic 
episodes to be delayed. These findings implicate the importance of 
oxygen availability during ischaemia (rather than during 
reperfusion) to the mechanisms responsible for reperfusion 
arrhythmogenesis. Hypoxia-induced lowering of intracellular ATP 
concentrations and/or a reduction of the affinity of active systems 
for ATP during hypoxia (Allen and Orchard,. 1987) may perturb ion 
homeostatic mechanisms to a degree that affects action potential 
characteristics. Noma (1983) has described a calcium-independent, 
ATP-regulated potassium channel in cardiac muscle that increases 
outward potassium currents at low (<0.2mM) ATP concentrations. In 
normal cardiac cells, the intracellular ATP concentration has been 
reported to be 3-4mM (Khairallah and Monmaerts, 1953), whereas 
during hypoxia, this concentration falls by some 90% (Grinwald et 
al, 1980). Noma (1983) suggested that activation of this potassium 
channel may reduce contractility (as observed during hypoxia; Allen 
and Orchard, 1987) and so preserve ATP levels by reducing ATP 
consumption. The results of the present study, which identified an 
increased efflux of 86Rb+ (above control values) following 
reperfusion after 2 min of hypoxic perfusion, might be explained by 
the existence of a potassium channel regulated by intracellular ATP 
concentrations. However, if this was the case, why was 86Rb+ efflux 
not elevated above control levels upon reperfusion after 12 min of 
hypoxic perfusion? One possible explanation involves the dilator 
effect of hypoxia. Prolonged hypoxic perfusion (12 min) reduced 
perfusion pressure almost two-fold compared with the shorter (2 
min) period of hypoxia. The former response was likely to be the
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result of metabolic vasodilation in both the occluded (hypoxic and 
ischaemic) zone and the non-occluded (hypoxic only) zone, whereas 
in the latter situation (2 min period of hypoxia), only the 
occluded zone is expected to have undergone metabolic (ischaemic 
only) dilation up to the time at which hypoxic perfusion was 
initiated. Thus, when hypoxia was induced before CAL, dilation of 
non-ischaemic vessels vrould be greater at the time of reperfusion 
than that seen when hypoxia was induced only 2 min before 
reperfusion. In effect, subjecting hearts to hypoxic conditions 
before the onset of ischaemia vrould reduce the relative difference 
between the diameter of vessels in the ischaemic and non-ischaemic 
vascular beds. This, through coronary steal, vrould reduce the rate 
of reperfusion and washout from the ischaemic zone.
None of the above hypotheses implicate the involvement of oxygen 
radicals in the arrhythmic and 86Rb+ efflux responses obtained 
using hypoxia protocols. It vrould seem straightforward to assume 
that by reducing the availability of oxygen, the generation of 
oxygen radicals vrould be limited. However, several other factors 
require to be considered. Firstly, was oxygen availability 
sufficiently restricted? Guamieri and colleagues (1980) employed 
an identical perfusion system to that used in the current study and 
found perfusate oxygen tensions for aerobically gassed (95% 02/5% 
CO2) and hypoxically gassed (95% N2/5% CO2 ) buffer solutions to be 
>600mriHg and <6nmHg respectively. In our laboratory, measurements 
using a non-airtight oxygen electrode showed hypoxic buffer to 
contain less than 10% of the oxygen content of aerobic buffer after 
passing through the heart perfusion apparatus. Whilst this
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demonstrates that nitrogen gassing severely reduced perfusate 
oxygen levels, it is possible that sufficient oxygen remained to 
allow oxygen radical generation. Furthermore, oxygen is 
approximately 8 times more soluble in organic solvents than in 
water (Halliwell and Gutteridge, 1985). The hydrophobic interior of 
biological membranes is thought to have the consistency of a light 
oil and it is therefore likely that oxygen will be retained in this 
compartment for some time, even under conditions of low oxygen 
tension. Finally, whilst hypoxic conditions may reduce the amount 
of oxygen radical production, this beneficial effect may be 
compromised by a reduced activity of cellular anti-free radical 
defence systems, as has been demonstrated and reviewad by Guamieri 
and co-workers (1980). Despite the above considerations, which 
require further experimental support, the hypoxia data presented 
earlier tend to indicate that oxygen radical generation during 
reperfusion of regionally ischaemic hearts is not a major factor in 
the development of reperfusion arrhythmias. It is suggested that 
metabolic changes within the heart under hypoxic conditions may 
ultimately affect the ionic homeostasis of excitable tissue and in 
this way may enhance the vulnerability of the heart to ventricular 
rhythm disturbances. The possibility that 86Rb+ efflux under these 
conditions is channel-regulated should be investigated further.
Hearts from DDC-treated rats underwent more episodes of tachycardia 
and longer durations of fibrillation than those from saline-treated 
controls, and this indicates a pro-arrhythmic role for 0 2 -". 
However, DDC is not specific for SOD enzymes. Heikkila and 
associates (1976) reported the use of DDC to inhibit aldehyde
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dehydrogenase in liver and dopamine beta-hydroxylase in adrenergic 
nerves. The pro-drug of DDC, disulfiram, is used in alcohol abuse 
therapy and exerts many potentially lethal side-effects including 
VT and acute congestive heart failure (see Bowman and Rand, 1980). 
Although the mechanisms involved in these actions are not known, 
Heikkila et al (1976) have shown disufiram to be relatively 
ineffective in inhibiting SOD. The possibility that the adverse 
tachycardia observed in the present investigation was similarly 
unrelated to SOD inhibition must preclude the assertion that 
enhanced 02-" production (resulting from reduced SOD-catalysed 
dismutation) was directly responsible for this effect despite 
evidence that DDC did indeed inhibit the enzyme in a cell-free 
system. Future vrork requires the measurement of myocardial SOD 
activity in hearts from DDC-treated animals to enable a direct 
comparison between SOD inhibition and the incidence of arrhythmias.
Finally, allopurinol has been shown to be antiarrhythmic in the 
isolated rat heart model via mechanisms that are apparently 
unrelated to the inhibition of xanthine oxidase. This was 
demonstrated by the lack of antiarrhythmic protection afforded by 
the active metabolite, oxypurinol. The mode of action of 
allopurinol has not been investigated in the present study, but 
DeWall and colleagues (1971) showed allopurinol treatment to 
.increase myocardial contractility and cardiac output, reverse 
ischaemia-induced S-T segment elevation and exhibit prolonged 
antiarrhythmic effects in anaesthetised dogs and sheep. Allopurinol 
also enhanced purine salvage and consequently maintained myocardial 
ATP levels. It is also possible that allopurinol exerts a direct
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action on myocardial conducting fibres, although the results of 
preliminary experiments using an ,larrhythmogenicM buffer solution 
suggested that the drug has no class I antiarrhythmic action. 
Additional studies are required to elucidate allopurinol' s node of 
action which, in the light of the results presented here, should 
not be confined to its role of xanthine oxidase inhibition.
In conclusion, several anti-free radical interventions have proved 
ineffective at preventing the genesis of reperfusion-induced 
arrhythmias in the isolated rat heart model. With respect to the 
6-CHDA and allopurinol data, there vrould not appear to be a 
consistent relationship between reperfusion arrhythmias and the 
magnitude of the accompanying 86Rb+ efflux, although it is 
interesting to note that both of these drugs have been associated 
with the maintainance of energy/substrate levels in the myocardium. 
GSH was the only free radical scavenging agent that afforded 
protection against arrhythmias, but these responses were 
complicated by substantial falls in perfusion pressure following 
addition of the drug. The importance of this dilator component is 
considered in chapter 5.
CHAPTER 5
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5.1 INTRQIXJCTION: THE ANTIARRHYTHMIC ACTION OF GLOTA1HICNE - 
CORONARY STEAL OR FREE RADICAL SCAVENGING?
Reduced glutathione (GSH) protects isolated rat hearts against the 
development of arrhythmias and reduces the efflux of 86Rb+ 
following coronary artery reperfusion (chapter 4). Interpretation 
of these results is complicated by the observation that GSH exerts 
a pronounced dilator action on the coronary circulation. The 
mechanism involved in this response has not been reported. Dilation 
of coronary vessels in the non-ischaemic area of myocardium may act 
to divert coronary flow from vessels serving the ischaemic zone, 
thereby reducing the rate at which ischaemic tissue is reperfused 
(the "coronary steal" effect). Since a reduction of the rate of 
reperfusion reduces the incidence of arrhythmias in this model 
(Zakaria, 1985), it is possible that the antiarrhythmic effect of 
GSH is not related to the drug's anti-free radical action. Whilst 
administration of GSH to isolated rat hearts 2 min before 
reperfusion has also been shown to reduce arrhythmias and 86Rb+ 
efflux (Zakaria, 1985), the possibility still remains that coronary 
dilation could have occurred within this 2 min period sufficient to 
allow coronary steal.
Free radical related cellular damage is accompanied by a reduction 
of tissue GSH levels (Guamieri et al, 1979; Ferrari et al, 1985), 
is accentuated by GSH depletion (Barsacchi et al, 1984; Harlan et 
al, 1984) and is attenuated by enhancement of intracellular GSH 
concentrations (Tsan et al, 1985). Protection against reperfusion 
arrhythmias by GSH has been demonstrated in isolated hearts
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(Woodward and Zakaria, 1985; Bernier et al, 1986) and has been 
ascribed to the free radical scavenging property of GSH, but 
little, if any, emphasis has been made on the dilator action and 
possible anti-ischaemic effects of this drug. Described below are 
the results of experiments designed to establish: (a) whether other 
sulphydryl-containing compounds exert similar responses in isolated 
hearts to those of GSH, and (b) if vasodilator drugs reproduce 
these effects.
The sulphydryl compounds employed in this study were 
d-penicillamine (PSH) and dithiothreitol (DTT). PSH is a copper 
chelating agent used in the treatment of Wilson's disease (an 
inherited disease characterised by low levels of the body's 
endogenous copper chelating agent caeruloplasmin) (Halliwell and 
Gutteridge, 1985) and as an anti-rheumatic drug (Roberts and 
Robinson, 1985). The mode of action of PSH in rheumatoid arthritis 
is unknown, although recent evidence (Roberts and Robinson, 1985) 
suggests that copper-PSH complexes exhibit SOD-like properties.
DTT, a disulphydryl compound, is commonly used in experimental 
studies to reduce disulphide groups to free thiols (Bellomo et al, 
1983; Thor et al, 1985; Nicotera et al, 1985) and as such is a 
useful tool in investigations of the importance of sulphydryl 
groups to cellular processes.
Vasodilator drugs are used clinically in the treatment of 
hypertension and congestive heart failure. In myocardial ischaemia, 
certain vasodilators have been shown to reduce ventricular filling 
and intramural coronary artery compression and so facilitate
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increased collateral blood flow (Elfellah and Ogilvie, 1985). In 
the present study, two vasodilator drugs, sodium nitroprusside 
(NITRO) and hydralazine (HYD), were used in an attempt to reproduce 
the degree of coronary dilation observed with GSH. Their 
concentrations were derived from preliminary dose-response studies 
in which reductions in PP, similar to those achieved with GSH, were 
obtained without any observable adverse effects on HR and dT.
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5.2 RESULTS: RESPONSES OF ISOLATED HEARTS TO SULPHYDRYL COMPOUNDS 
AND VASODILATOR DRUGS
5.2.1 Arrhythmias
(a) Sulphydryl compounds: PSH and DTT:
Neither PSH (O.lmM and lmM) or DTT (O.lmM and lmM) significantly 
affected the incidences of VT or VF upon reperfusion (figure 
5.2.1). The onset and duration of arrhythmias and the number of 
PVC's were similarly unaffected (table 5.2.1).
(b) Vasodilator drugs: NITRO and HYD:
NITRO (O.OIjjM and O.ljiM) was without effect on the incidence of 
arrhythmias in reperfused hearts (figure 5.2.1). However, O.OlpM 
NITRO significantly prolonged the duration of VF from the control 
value of 75+13s to 148±14s (table 5.2.1). The incidences of VT and 
VF in hearts perfused with HYD were also statistically unaffected 
(figure 5.2.1), although this drug delayed the onset of both types 
of arrhythmia (table 5.2.1). The first episode of VT occurred after 
36+14s, a significant increase compared with 6+ls in control 
hearts. VF was observed 36+7s after reperfusion, almost three times 
the value for the control group (13+2s). HYD also reduced the 
number of PVC's from 199+30 (control) to 72+25. Antiarrhythmic 
protection with vasodilator drugs was therefore minimal despite 
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Figure 5.2.1:
The percentage incidence of VT (open bars) and VF (shaded 
bars) following reperfusion in control hearts (n=43) and 
hearts perfused with sulphydryl compounds or vasodilator 
drugs.
GSH, glutathione (O.OlmM, O.lmM, lmM n=10, 12, 27 
respectively); PSH, d-penici 1 lamine (O.lmM n=12, lmM n=13); 
DTT, dithiothreitol (lmMn=12); NITRO, sodium nitroprusside 
(O.OlpM n=ll, 0.lpM n=10); HYD, hydralazine (O.lmM n=10).





















































10-4M 10 6 36±14* 7+ 2 5 36± 7* 111±22 72+251
Table 5.2.1:
The onset and duration of VT and VF and the number of PVC's during the 
first 3 min of reperfusion in control hearts and hearts perfused with 
sulphydryl compounds or vasodilator drugs.
PSH, d-penicillamine; DTT, dithiothreitol; NITRO, sodium nitroprusside; 
HYD, hydralazine.
* p<0.05 compared with the control value.
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5.2.2 86Rb+ Efflux
(a) Sulphydryl compounds: PSH and DTT:
Attenuation of the reperfusion-induced efflux of 86Rb+ by lmM GSH 
(chapter 4 and figure 5.2.2) was also observed in hearts perfused 
with PSH (figure 5.2.2). O.lmM PSH reduced the control mean peak 
ere value (0.076+0.010 min”1) to 0.037+0.003 min-1 and the control 
efflux area (0.133+0.023 au) to 0.037+0.009 au. Corresponding 
significant reductions with lmM PSH were 0.041+0.002 min-1 and 
0.026+0.009 au. Unlike GSH however, the low efflux values seen 
with PSH did not correspond with an antiarrhythmic action.
Hearts perfused with O.lmM DTT exhibited mean peak ere and mean 
efflux area values that were not significantly different to those 
of the control group, whereas lmM DTT significantly reduced mean 
peak ere to 0.049+0.006 min-1, but was without effect on mean 
efflux area (figure 5.2.2).
(b) Vasodilator drugs: NITRO and HYD:
Both vasodilator drugs significantly attenuated the reperfusion- 
induced rise of 8 6Rb+ efflux (figure 5.2.3). 0.lpM NITRO 
lowered mean peak ere to a value of 0.042+0.004 min-1 and mean 
efflux area to 0.055+0.013 au. O.OlpM NITRO decreased mean peak ere 
and mean efflux area to values of 0.046+0.008 min-1 and 0.044+0.013 
au respectively. There appeared to be no positive correlation 
between arrhythmia incidence and 86Rb+ efflux following reperfusion 
of NITRO-perfused hearts (figure 5.2.3). Whilst the incidences of VT 
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Figure 5.2.2
Reperfusion-induced rubidium-86 efflux in control hearts (n = 21) and 
hearts perfused with sulphydryl compounds.
Vertical bars represent mean peak ere (min \ open bars) and mean 
efflux area (.au, shaded bars), with corresponding standard errors 
(vertical lines), for the first 3 min of reperfusion.
GSH, glutathione (0.01 mM, 0.1 mM, 1 mM, n = 6, 5 and 21 respectively); 
PSH, d-penicillamine (0.1 mM, n = 6; 1 mM, n = 6); DTT, dithiothreitol 
(0.1 mM, n = 6; 1 mM, n = 6).
*p^ !0.05 compared with the control group.
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Figure 5.2.3
Reperfusion-induced rubidium-86 efflux in control hearts (n = 21) and 
hearts perfused with vasodilator drugs.
Vertical bars represent mean peak ere (min \ open bars) and mean 
efflux area (au, shaded bars), with corresponding standard errors, 
for the first 3 min of reperfusion.
NITRO, sodium nitroprusside (0.01 jaM, n = 5; 0.1 pM, n = 8);HYD, 
hydralazine (0.1 mM, n = 5).
* p$0.05 compared with the control group.
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statistically significant. The attenuations of mean peak ere 
(0.036+0.002 min-1) and mean efflux area (0.026+0.011 au) were 
significant however, demonstrating further a dissociation between 
arrhythmogenesis and 86Rb+ efflux.
5.2.3 Haemodynamic Changes
(a) Sulphydryl compounds: PSH and DTT:
In chapter 4, GSH was shown to produce a pronounced, concentration- 
dependent dilator response in isolated hearts. PSH and DTT produced 
similar reductions of PP to that seen with O.lmM GSH (figure 
5.2.4). 0. OlmM PSH and lmM PSH lowered PP by 16+3mmHg and 25+4mriHg 
respectively. These changes were statistically significant. O.lmM 
and lmM DTT induced respective reductions of 18+4mmHg and 15+3mmHg, 
both of which were also significant dilatations.
Both drugs exhibited a bradycardic action. O.lmM PSH caused HR to 
fall significantly by 10+3 bpm and a significant drop of 11±4 bpm 
was observed with lmM PSH. The effects of DTT on HR were more 
pronounced. At a concentration of O.lmM, DTT lowered the rate by 
23+2 bpm whilst lmM DTT induced a fall of 27+4 bpm (figure 5.2.4).
The depressive action of these drugs was further illustrated by 
their effects on dT. Significant reductions of dT of 0.80±0.32g and 
1.14+0.29g were obtained with O.lmM and lmM PSH respectively, while 
O.lmM and lmM DTT caused contractility to fall by 0.67+0.20g and 
0.80+0.35g respectively. These changes were similar to those seen 
with O.lmM GSH (-0.61+0.36g) and lmM GSH (-0.91±0.28g) (figure
Figure 5.2.4:
Haemodynamic responses of isolated rat hearts to sulphydryl 
compounds.
Results are expressed as the mean and standard error of the 
change observed following drug perfusion.
GSH, glutathione; PSH, d-penicillamine; DTT, dithiothreitol.
* p<0.05 compared with the pre-treatment value.
For mean pre-treatment values, see figure 4.2.3.
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In summary, all three sulphydryl compounds (GSH, PSH and DTT) 
produced coronary dilatation, and their effects on dT were similar. 
DTT was peculiar in its bradycardic action which was more 
pronounced than that seen with GSH and PSH.
(b) Vasodilator drugs: NITRO and HYD:
O.lmM HYD exerted a pronounced dilator action (PP fell by 
28+7mmHg), similar to that produced by GSH, which was accompanied 
by insignificant changes in HR and dT. O.OlpM NITRO also produced a 
significant drop of PP of 12±2mmHg, but only at a concentration of 
O.lpM NITRO was the dilation observed (17±4mmHg) of similar 
magnitude to that induced by GSH. However, at this concentration, 
dT also fell by 1.12±0.31g (figure 5.2.4).
Despite HYD's ability to reproduce the haemodynamic actions of GSH, 
the vasodilator was unable to protect hearts against arrhythmias. 
These results therefore support the hypothesis that the 
antiarrhythmic effects of GSH ware not solely related to its 
dilator action.
Coronary dilation responses to GSH, PSH, DTT, NITRO and HYD were 
consistent with reductions of the elevation of 86Rb+ efflux on 
reperfusion, although the dilation produced by DTT (which was of an 
approximate magnitude to that seen with NITRO) was only accompanied 
by a lowering of mean peak ere; mean efflux area was unaffected.
Figure 5.2.5:
Haemodynamic responses of isolated rat hearts to vasodilator 
drugs.
Results are expressed as the mean and standard error of the 
change observed following drug perfusion.
NITRO, sodium nitroprusside (O.OlpM, n=ll; O.lOpM, n=10); 
HYD, hydralazine (O.lOmM, n=10).
* p<0.05 corpared with the pre-treatment value.
For mean pre-treatment values, see figure 4.2.3.
CHANGE IN PERFUSION PRESSURE(mmHg)
I—I
O  EC 
•—  -<  
=1 o
CHANGE IN dT(g) CHANGE IN HEART RATE(bpm)
*
II IK i5 iouo o
99
5.3 DISCUSSION
The overall effects of GSH on the haemodynamic functions of 
isolated rat hearts were depressive and manifested mainly as a 
marked and concentration-dependent reduction of perfusion pressure. 
Similar responses were obtained with the tvro other sulphydryl 
compounds studied, PSH and DTT. These also reduced perfusion 
pressure by a similar magnitude to that observed with GSH, although 
clear dose-response relationships were not demonstrated.
Preliminary experiments using the vasodilator drugs sodium 
nitroprusside and hydralazine produced dose-related reductions in 
perfusion pressure which, at the concentrations used, were similar 
in effect to GSH.
Since all drugs were perfused through hearts before coronary 
ligation, it was conceivable that coronary steal protection against 
arrhythmias might occur. However, the results presented in this 
chapter do not indicate that this was the case. Despite the ability 
of all drugs tested to evoke substantial and similar reductions of 
perfusion pressure, only GSH was shown to be antiarrhythmic, 
suggesting that this drug has alternative actions. Whilst there are 
a multitude of cellular processes that are regulated by 
thiol-disulphide redox reactions, a factor which complicates 
interpretation of the effects of exogenous sulphydryl drugs, two 
other important points should be considered. Firstly, PSH and DTT 
are not substrates for glutathione peroxidase (Jones et al, 1983;
B.Swann, personal communication) and cannot, therefore, participate
100
in the breakdown of H2O2 . Secondly, the high water solubility of 
GSH, PSH and DTT suggest that these compounds cannot cross cell 
membranes in the absence of specific uptake mechanisms. No such 
mechanisms have been described for PSH and DTT. However, Meister 
and Anderson (1983) have reviewed evidence indicating that GSH 
uptake may occur. Extracellular GSH is broken down to 
gamma-glutamyl amino acids by an enzyme, gamma-glutamyl 
transpeptidase, located on the outer surface of the plasma 
membrane. The amino acid substrate for this enzyme is cystine and 
the product of the reaction, gamma-glutamyl cystine, is transported 
into the cell where it becomes a substrate for a transhydrogenation 
reaction resulting in the formation of the oxidised (disulphide) 
form of cystine, cysteine. The intracellular enzyme gamma-glutamyl 
cysteine synthetase uses cysteine and glutamine in an ATP-requiring 
reaction to produce gamma-glutamyl cysteine. A second 
energy-requiring reaction, catalysed by GSH synthetase, generates 
GSH from gamma-glutamyl cysteine and glycine. Unfortunately, the 
existence of such a sequence has not been investigated in cardiac 
tissue, and the requirement for ATP implies that the process is too 
slow and limited to be of importance during the time course of the 
experiments described earlier. However, the possibility that a GSH 
uptake system does exist in the heart provides a wide and 
interesting scope for future studies. At present, the 
antiarrhythmic effects of exogenous GSH cannot be explained from 
the results described; an anti-free radical mode of action cannot 
be discounted. It would appear, though, that dilator-mediated 
coronary steal is not an important antiarrhythmic factor in the 
isolated rat heart model.
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Interestingly, it has also been shown that the other sulphydryl 
agents and the vasodilator drugs, which were not antiarrhythmic, 
also attenuated the reperfusion-induced rise in 86Rb+ efflux. This 
infers that a6Rb+ efflux is not exclusively the cause or the 
consequence of arrhythmogenic mechanisms. However, such a 
conclusion would be premature in the absence of data showing the 
effects of sulphydryl and vasodilator agents on 86Rb+ uptake and 
efflux in both the ischaemic and non-ischaemic regions. Even though 
the efflux of 86Rb+ was reduced upon reperfusion of the ischaemic 
region, this does not necessarily indicate that tissue 
heterogeneity was similarly reduced. Whilst a direct relationship 
between the magnitude of the induced fall in perfusion pressure and 
the attenuation of 86Rb+ loss has not been clearly demonstrated, it 
would seem logical to suggest that dilation-induced redirection of 
coronary flow from ischaemic vessels upon reperfusion contributed 
to the lowering of 86Eb+ efflux from this area of tissue. However, 
previous results (chapter 4) demonstrated falls in perfusion 
pressure with desferrioxamine and oxypurinol without accompanying 
reductions of 86Rb+ efflux and so preclude vasodilation as a major 
factor in this response. The reduction of 86Rb+ efflux by 
vasodilator drugs (NITRO and HYD) was concentration-dependent 
however, and so complicates further the interpretation of the 
relationship between 86Rb+ efflux and the dilator effects of GSH, 
PSH, DTT, desferrioxamine and oxypurinol. Any explanation must be 
speculative, and it would appear that proportionality between 
dilation and efflux is the normal response which was modified by 
additional actions of the above drugs. Evidence associating
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intracellular or membrane-bound thiol groups with the regulation of 
potassium transport has however, been cited by many authors. Maury 
and colleagues (1980) demonstrated that the oxidation of critical 
thiol groups involved in potassium gating causes an increased 
outflow of potassium through Escherichia coli membranes. The 
transport mechanism was thought to be channel-regulated, since 
thiol oxidation with N-ethylmaleimide did not inactivate potassium 
pump systems. In pancreatic islet cells, 86Rb+ efflux is reduced by 
agents that increase intracellular NAD(P)H concentrations and by 
GSH itself (Henquin, 1980). Modifications of the NAD+/NADH ratio in 
intact human erythrocytes similarly modulates the activity of 
calcium-dependent potassium transport (Alverez et al, 1986). 
Increases in cellular levels of reduced nicotinamide dinucleotides, 
as a direct result of elevated lactate concentrations, increase the 
affinity of calcium-activated potassium channels for calcium, 
leading to enhanced uptake of 86Rb+. Although Alvarez's group did 
not monitor 86Rb+ efflux, their evidence indicates that 
calcium-dependent potassium transport is modulated by redox 
reactions. Despite the need for more detailed investigations of 
cellular thiol-disulphide interactions, and of their role in ion 
transport systems, it is suggested that modification of the redox 
state of free thiols by GSH, PSH and DTT in the present study 
significantly contributed to the observed attenuation of 86Rb+ 
efflux following reperfusion and that these effects did not appear 
to be concentration-dependent owing to the superinposed effects of 
dilatation.
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NITRO is believed to act by elevating intracellular cyclic GMP 
(cGMP) levels via activation of guanylate cyclase (Rapoport et al, 
1981). cGMP has reciprocal actions to those of cAMP and is, as 
such, an important regulator of intracellular calcium 
concentrations. It is therefore likely that NITRO-induced 
alterations of cellular calcium mobilisation will alter the 
movements of other cations via cation exchange. The mode of action 
of HYD is less well understood, but it is believed to exert a 
direct effect on smooth muscle. Jacobs (1984) demonstrated an 
HYD-dependent inhibition of act in-myosin interaction in an in vitro 
myofibril preparation. The effects of the drug on cation fluxes 
have not been described.
The initial objective of the work described in this chapter was to 
determine whether GSH is antiarrhythmic in the isolated heart model 
by virtue of its vasodilator action. The results suggest that this 
was not the case, although the precise mechanisms involved have not 
been determined. Future work should aim at identifying and 
dissociating the anti-free radical properties of this drug from 
other less specific, though no less important, effects on cellular 
free thiols and regulatory redox reactions.
Finally, these data highlight the need for more detailed analyses 
of both efflux and uptake kinetics of 86Rb+ in both ischaemic and 
non-ischaemic tissues. Data aquired from such studies should allow 
the conclusive identification and magnitude of the washout 
component following reperfusion and of the transport systems 
involved in reperfusion-induced alterations to potassium fluxes.
CHAPTER 6
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6.1 INTRODUCTION: XANTHINE OXIDASE AND FREE RADICAL REACTIONS IN 
THE HEART
Data presented so far demonstrate a similarity between the effects 
of the exogenous administration of xanthine oxidase to isolated 
hearts and those of reperfusion following regional myocardial 
ischaemia. 86Rb+ efflux rose following both xanthine oxidase 
administration and reperfusion (chapter 3). The former was reduced 
by SOD, and Zakaria (1985) attenuated the reperfusion-induced 
elevation of 86Rb+ efflux using a combination of the free radical 
scavengers SOD, catalase and mannitol. Reperfusion of isolated rat 
hearts was also shown to produce a ferricytochrome c-reducing 
species at a time when reperfusion arrhythmias were initiated 
(Woodward and Zakaria, 1985); both ferricytochrome c reduction and 
arrhythmias were reduced in the presence of SOD. Bernier et al
(1986) have since confirmed the antiarrhythmic properties of 
anti-free radical interventions. These findings provide 
considerable (albeit circumstantial) evidence that oxygen free 
radicals are involved in the genesis of arrhythmias and the 
elevation of 86Rb+ efflux following coronary reperfusion in 
isolated rat hearts.
The experiments described in section 6.2 were undertaken to confirm 
that the xanthine/xanthine oxidase free radical-generating system 
was indeed generating oxygen radicals in the hearts. It was 
necessary to establish this in order to give credence to the 
effects of the system on 86Rb+ efflux (chapter 3) being ascribed to 
oxygen radicals. Xanthine oxidase has itself been postulated as an
105
endogenous source of free radicals during ischaemia/reperfusion.
Roy and McCord (1983) showed that the conversion of xanthine 
dehydrogenase (which utilises NAD+ as an electron acceptor) to the 
oxidase (which utilises O2 as an electron acceptor) occurs in many 
tissues. 50% conversion to the oxidase in the rat heart was seen 
within 5 min of ischaemia, a time corresponding to the peak 
duration of ischaemia required to evoke the highest incidence of 
reperfusion arrhythmias in this species (Manning and Hearse, 1984). 
Roy and McCord (1983) proposed that the substrate-starved and 
oxygen-deprived tissue is depleted of high energy phosphates such 
as ATP. ATP is catabolised to AMP, adenosine, inosine and finally 
hypoxanthine and xanthine, the substrates for xanthine oxidase. The 
fall in energy levels in the cell is proposed to result in a 
redistribution of cations which Roy and McCord suggested causes an 
increased calcium influx that activates intracellular proteases 
capable of converting the dehydrogenase to the oxidase. Soybean 
trypsin inhibitor (STI), which inhibits the activity of proteases, 
has indeed been shown to prevent enzymic conversion in rat
intestine (Roy and McCord, 1983). The cell, having accumulated the
;
substrates (hypoxanthine and xanthine) and the enzyme (xanthine 
oxidase), is now "primed" for the production of free radicals when 
the final substrate, O2 , becomes available (i.e. upon reperfusion).
The above scheme of events is attractive and it is tempting to 
extrapolate its occurrence to the heart. In fact allopurinol and 
folic acid, both inhibitors of xanthine oxidase, were shown to 
reduce the incidence of reperfusion arrhythmias in the rat (DeWall 
et al, 1971; Manning et al, 1984). However, the distribution of
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xanthine oxidase varies in different tissues of the same species 
and in the same tissues in different species (Parks and Granger, 
1986). Whilst the enzyme may be important in the genesis of 
reperfusion arrhythmias in the rat, its activity is negligable in 
the rabbit heart (Schoutsen and de Jong, 1987) and is yet to be 
demonstrated in the human heart. The final study to be described 
was therefore aimed at establishing the presence, location and 
activity of xanthine dehydrogenase and xanthine oxidase in 
cardiovascular cells. Where possible, cells derived from rat hearts 
were used, but since rat coronary smooth muscle and endothelial 
cells were not easily available, rat aortic smooth muscle cells and 
human umbilical endothelial cells were substituted. Enzyme 
detection involved the measurement of xanthine oxidase-derived 
oxygen radicals using luminol-enhanced chemiluminescence. This 
technique has been used by others (Miura and Ogiso, 1985) to 
measure xanthine oxidase activity in cell-free systems.
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6.2 RESULTS: THE XANTHINE/XANTHINE OXIDASE SYSTEM
6.2.1 Demonstration of Free Radical Generation by Xanthine Oxidase, 
and Free Radical Scavenging by SOD, in Isolated Non-ligated 
Rat Hearts
Table 6.2.1(a) shows the percentage increase in the rate of 
ferricytochrome c (FeCyt c) reduction (i.e. % optical density 
increase per min; %dE/min) induced by xanthine oxidase in 
non-ligated hearts. In the absence of the enzyme's substrate 
xanthine, bolus additions of xanthine oxidase (0.65 U and 1.30 U) 
caused dE/min to increase by 14+2% and 17+3% respectively. During 
perfusion with O.lmM xanthine, 0.65 U xanthine oxidase elevated 
dE/min by 44+2%, a significant rise when compared with the 1+1% 
increase observed with the enzyme vehicle (3.2M aimonium 
sulphate/0.02% sodium salicylate). The change achieved with 0.65 U 
was apparently maximal, since 1.30 U did not produce a 
significantly greater change.
Concomitant perfusion with SOD (10 U/ml) significantly attenuated 
resposes to xanthine oxidase in the presence and absence of 
xanthine (table 6.2.1(a)).
There appeared to be sufficient substrate in hearts to allow some 
radical generation, since FeCyt c was reduced by xanthine oxidase 
in the absence of exogenous xanthine. This is demonstrated further 
by the results presented in table 6.2.1(b), which were obtained 
from identical perfusion experiments in the absence of hearts. With
PERFUSATE COMPOSITION BOLUS (0.01ml) ADDITIONS MEAN % INCREASE OF 
__________________________________    E550nm + sem
XANTHINE SOD VEHICLE XANTHINE OXIDASE
(O.lmM) (10 U/ml) 0.65 U 1.30 U (a) (b)
- - + - - 0+0 0±0
- - - + - 14+2* l+lb
- - - - + 17±3* 0±0b
+ _ + _ _ 1+1 0+0
+  ■ ■ ■ ■ -  ■ ■ . . . . + 44+2* 48+2*
+ - - - + 45±3* 52±2*
— + + — _ 0+0 0+0
- + - + - 3+la 1+1
— + - - + 7 ± l * a l±lb
+ + + _ — 2+1 0+0
+ + - + - 15+3*a 21±l*a
+ + - - + 20+2*a 28+2*a
Table 6.2.1:
The reduction of ferricytochrcme c (mean percentage increase of E550nm) in 
(a) coronary effluent from isolated rat hearts and (b) perfusion fluid 
which has not passed through hearts (n=3 per group).
+/- represents the presence/absence of each agent.
* p<0.05 compared with the vehicle control value
a p<0.05 compared with the corresponding value in the absence of SOD
b p<0.05 compared with the corresponding value in column (a).
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this protocol, xanthine oxidase (0.65 U and 1.30 U) had a 
negligable effect on the rate of optical density change (1±1% and 
0+0% respectively) when xanthine was omitted from the perfusate. 
These changes were significantly smaller than those observed in 
experiments using hearts (14+2% and 17+3% respectively; table 
6.2.1(a)). The inhibitory effect of SOD was unaffected in these 
experiments.
Notabley higher rates of optical density change were obtained with 
xanthine/xanthine oxidase when hearts were not used in these 
experiments (table 6.2.1). It is possible that the heart tissue in 
the previous experiments provided a site for radical chain 
termination reactions, such as lipid peroxidation, which would have 
competed for the reaction site on the FeCyt c molecule, thus 
lowering the observed rate of FeCyt c reduction.
These results demonstrate that the xanthine/xanthine oxidase system 
generates species in isolated rat hearts that are scavenged by SOD. 
Since SOD is specific for the dismutation of 02-" (Halliwell and 
Gutteridge, 1985), this radical was likely to be the species in 
question.
6.2.2 Purification of Commercial Xanthine Oxidase
In the above experiments, commercially obtained xanthine oxidase 
was shown, in the presence of xanthine, to generate free radicals, 
and was previously shown to elevate a6Rb+ efflux in non-ligated 
hearts (chapter 3, section 3.2.4). The vehicle in which the enzyme
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is supplied comprises 3.2M ammonium sulphate and 0.02% sodium 
salicylate. Freshly prepared solutions of vehicle did not affect 
FeCyt c reduction (table 6.2.1) or 86Rb+ efflux, as demonstrated by 
the results described in section 3.2.4 and illustrated in bar chart 
form in figure 6.2.1. However, Fridovich (1982) has reported that 
exposure of xanthine oxidase to very high salt concentrations may 
deflavinate the enzyme to a form (deflavoxanthine oxidase) that 
directly reduces FeCyt c. It was necessary to demonstrate that 
responses to xanthine oxidase were O2 • "-mediated. The enzyme 
vehicle was therefore removed by dialysis in 0.9% (w:v) saline, or 
by gel filtration using a Sephadex G-25 column.
Following gel filtration of xanthine oxidase, eluent samples were 
assayed for their relative protein content and subjected to a 
barium sulphate precipitation test to identify samples that 
contained vehicle sulphate (figure 6.2.2). A good separation was 
achieved between protein-containing samples and samples that were 
barium sulphate positive. Samples were pooled into four fractions 
(figure 6.2.2), assayed for protein and, together with dialysed 
enzyme samples, subjected to the standard cell-free FeCyt c assay 
for determination of xanthine oxidase activity. Table 6.2.2 shows 
that the activity of the desalted enzyme (fraction 1) compared 
favourably with the activity of the commercial enzyme sample 
(0.50+0.02 and 0.054+0.01 absorbance units/min/mg protein 
respectively). No enzyme activity was observed in fractions 2 to 4. 
Dialysed enzyme samples exhibited enzyme activities which were of 
the same order of magnitude as those seen with the commercial 























86Rb+ efflux in non-ligated hearts induced by 
bolus additions (0.01ml) of 0.65U xanthine oxidase, alone 
(XO, n=4), in the presence of O.lmM xanthine (XANTH/XO, n=5) 
or in the presence of O.lmM xanthine and lOU/ml SOD 
(XANTH/SOD/XO, n=6). The control group (VEHICLE) was 
administered 0.01ml of enzyme vehicle (n=3).
Mean and standard errors are shown for peak ere (open bars) 
and efflux area values (shaded bars).
* p<0.05 compared with the control group.
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Figure 6.2.2
Relative protein content (E280 nm) of eluent samples of commercially 
available xanthine oxidase following Sephadex G-25 gel filtration (n = 1).
Each tube contained 1 ml of eluent collected over 2 min.
Samples shown to contain sulphate are denoted by S.
SAMPLE
(0.01ml)
RATE FeCyt c REDUCTION 
(abs. unit/min/mg protein) 
+sem











The reduction of ferricytochrome c by xanthine oxidase (XO). Samples of 
commercially available enzyme were tested before and after (fractions 1-4) 
Sephadex G-25 gel filtration or dialysis.
Values are the rate of optical density change (at 550nm) per milligramme 
of total sample protein. The mean and standard error of 2 
spectrophotometric determinations are shown for each assay group.
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vehicle for commercial xanthine oxidase did not contribute to the 
reduction of FeCyt c, indicating that the commercial preparation 
reduced FeCyt c via a O2 • "-dependent mechanism. The activities of 
desalted and commercial samples of the enzyme did not significantly 
differ.
6.3 RESULTS: THE LOCATION AND ACTIVITY OF XANTHINE OXIDASE AND 
XANTHINE DEHYDROGENASE IN CARDIOVASCULAR CELLS
The in situ generation of free radicals by xanthine oxidase in the 
heart may contribute to the genesis of reperfusion arrhythmias 
(section 6.1). This hypothesis assumes the existence of the enzyme 
in hearts. A study was therefore undertaken, using cultured 
cardiovascular cells, to determine the locations and activities of 
xanthine oxidase and dehydrogenase. Luminol-enhanced 
chemiluminescence detection of free radicals generated by xanthine 
oxidase was carried out on rat aortic vascular smooth muscle (vsm) 
cells, adult rat cardiac myocytes, neonatal rat cardiac myocytes, 
rat cardiac fibroblasts and human umbilical vein endothelial cells. 
Xanthine dehydrogenase (which does not generate free radicals) was 
detected after sulphydryl oxidation to the oxidase with DTNB (Clare 
et al, 1981). Both enzyme activities were measured within 4 min of 
lysing the cells.
6.3.1 Verification of the Generation and Detection of Superoxide or 
Superoxide-derived Free Radicals
The addition of increasing quantities of xanthine oxidase to cell
Ill
medium produced dose-dependent increases in instantaneous 
chemiluminescence, as has been observed in cell-free systems (Miura 
and Ogiso, 1985). This relationship was linear up to 10 mU xanthine 
oxidase (figure 6.3.1). The inclusion of 10 U SOD in these 
experiments significantly reduced photon emission at all time 
points (figure 6.3.2), indicating that increased photon emission 
following xanthine oxidase addition was the result of O2 •" or 
0 2 - "-derived radical formation.
The addition of 5 mU xanthine oxidase to cell media (DMEM, HAMS F10 
(xlO) and medium 199) containing 0.4mM xanthine produced increases 
in photon emission (31+1 cps, 33+1 cps and 33+1 cps respectively) 
which did not significantly differ, indicating that the 3 media had 
similar antioxidant properties.
6.3.2 Qienuluminescence Bnission from Cells
Photon emission from each of the 5 cell preparations is shown in 
figure 6.3.3(A to E). In none of the cells was xanthine oxidase 
activity detected on the extracellular surface, since 
chemiluminescence did not increase on addition of luminol.
Following cell lysis with Triton-XlOO, chemiluminescence was 
detected primarily in endothelial cells (figure 6.3.3D), although 
smaller but significant increases in count rate were also observed 
in the other cell types. Chemiluminescence on addition of DTNB 
occurred mainly in endothelial cells, with the other cells 
exhibiting much smaller responses. At the end of each experiment,
XANTHINE OXIDASE ACTIVITY(mU)
Figure 6.3.1
The increase in chemiluminescence (counts per second, cps) induced by 
increasing quantities of xanthine oxidase.
Each point is the mean change of 10 counts. Standard error bars are 
smaller than each data point.
200
ISmU XO





o 5 0 -
20 40 60 80 100 120 140 160 180 200
TIME(seconds)
Figure 6.3.2
Chemiluminescence induced by the addition of 15 mU xanthine oxidase in 
DMEM medium containing 0.4 mM xanthine and 2 mg/ml luminol.
Experiments were carried out in the presence (X) and absence (■) of 
10 U SOD ( n = 1 per group).
Figure 6.3.3:
Chenriluminescence emission from 5 cell preparations.
Measurements were made in the presence of 0.4mM xanthine on 
(A) adult rat myocytes, (B) neonatal rat myocytes, (C) rat 
aortic (A10) vsm cells, (D) human umbilical vein endothelial 
cells, and (E) rat cardiac fibroblasts.
Additions of 0.04ml volumes of luminol (2mg/ml), triton-XlOO 
(1% v:v), 5,5' dithiobis-2-nitrobenzoic acid (DTNB, 5mM), and 
xanthine oxidase (XO, 5mU) were made at the times indicated.
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5 mU xanthine oxidase were added as a positive control to correct 
for different quenching of chemiluminescence by the media and 
phototube responsiveness on the day of the experiment. It was also 
used, in conjunction with protein determinations on different but 
similarly prepared plates of cells, to quantify the activities of 
xanthine oxidase and xanthine dehydrogenase.
6.3.3 Xanthine Oxidase/Dehydrogenase Activities in Cultured Cells
Substantial xanthine oxidase activity was observed in endothelial 
cells (27.4+7.2 mU/mg protein; table 6.3.1). Neonatal myocytes and 
vsm cells exhibited less activity, whilst adult myocytes and 
cardiac fibroblasts showed negligable enzyme activity.
Xanthine dehydrogenase-derived oxidase activity was again highest 
in endothelial cells (16.5+5.8 mU/mg protein), and the ratio of 
dehydrogenase to oxidase activity in these cells was 0.6:1. The 
ratio in vsm cells was approximately 0.3:1. Neonatal myocytes were 
peculiar in exhibiting a greater dehydrogenase to oxidase activity 
(2:1). Adult myocytes and cardiac fibroblasts had very low enzyme 
activities in a 1:1 ratio (table 6.3.1).
In order to confirm that the substantial chemiluminescence observed 
in the human endothelial cells arose from xanthine oxidase 
activity, experiments on these cells were repeated in the presence 
and absence of lpM oxypurinol (figure 6.3.4). The xanthine oxidase 
inhibitor significantly reduced photon emission at all time points 
after additions of Triton-XlOO and DTNB.
CELL TYPE ENZYME ACTIVITY (mU/mg total cell protein) 
XANTHINE OXIDASE XANTHINE DEHYDROGENASE
HUMAN ENDOTHELIAL CELLS 27.4±7.2 16.5±5.8
ADULT MYOCYTES 0.4±0.3 0.5±0.2
A10 VSM CELLS 15.4±2.8 4.4±2.4
CARDIAC FIBROBLASTS 2.2±0.5 1.8±0.2
NEONATAL MYOCYTES 4.7+0.3 8.0+4.5
Table 6.3.1:
Xanthine oxidase and xanthine dehydrogenase activities in 5 cardiovascular 
cell preparations.
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Chemiluminescence emission from human endothelial cells in 
the presence (O) and absence (#) of lpM oxypurinol.
Cells were bathed in medium 199 containing 0.4mM xanthine. 
Additions of 0.04ml volumes of luminol (2mg/ml), triton-XlOO 
(1% v:v), 5,5'dithiobis-2-nitrobenzoic acid (DTNB, 5mM) and 
xanthine oxidase (XO, 5mU) were made at the times indicated.




The results presented demonstrate that the xanthine/xanthine 
oxidase free radical generating system, first characterised by 
McCord and Fridovich (1968), did in fact produce 02-" or 
O2 •“-derived radicals in isolated hearts. The vehicle in which the 
commercially prepared enzyme is presented did not affect FeCyt c 
reduction and so it can be stated with some degree of certainty 
that the responses of isolated hearts following administration of 
the enzyme (chapter 3) were the direct result of oxygen radical 
generation. This conclusion is supported further by the work of 
Zakaria (1985), who abolished the xanthine oxidase-induced 
reduction of FeCyt c by previously inactivating (boiling) the 
enzyme. In the absence of more direct methods for measuring O2 • ~ 
production, the FeCyt c assay has proved to be a good alternative 
for qualitative and quantitative radical measurement in perfused 
tissue systems.
It has also been shown that luminol -enhanced chemiluminescence is 
both a rapid and reproducible technique for the assay of xanthine 
oxidase and xanthine dehydrogenase in small quantities of cells. 
Measurements of the instantaneous chemiluminescence derived from 
the cells were successfully used to quantify enzyme activities even 
though the signals were transient. It is possible that the 
instantaneous value is artificially high because of locally high 
concentrations of enzyme around the newly lysed cells. However, 
this is most unlikely since a transient signal was also observed
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when DTNB was added to the, by then, homogeneous lysate suspension. 
Whilst transient increases in chemiluminescence have also been 
observed in solution measurements of xanthine oxidase activity 
(Miura and Ogiso, 1985), the possibility remains that the transient 
increases in photon emission obtained following cell lysis or on 
addition of DTNB were the result of varying inherent radical 
scavenging capacities of the cells. Addition of 5 mU xanthine 
oxidase, the positive control, produced photon emission which (with 
the exception of vsm cells) tended to rise over the interval 
observed. This may indicate that the endogenous antioxidant 
properties of the cells were overwhelmed at this concentration of 
enzyme. Figure 6.3.1 provides some indication that the rate of 
increase of chemiluminescence is proportional to the activity of 
the added enzyme in the absence of cells.
The data that show the majority of xanthine oxidase activity to be 
located in endothelial and vsm cells is in agreement with previous 
qualitative experiments (Jarasch et al, 1981; Bruder et al, 1982; 
Wems et al, 1986). Xanthine dehydrogenase is similarly located 
overwhelmingly in the vasculature, with the exception of neonatal 
myocytes. These findings imply that the greatest generation of free 
radicals by endogenous xanthine oxidase would occur in the 
vasculature, even if xanthine dehydrogenase is a potential "store" 
of oxidase for radical production under pathological conditions. It 
is interesting to note that neonatal myocytes are peculiar in 
exhibiting a high dehydrogenase:oxidase ratio. This may represent a 
developmental stage leading to the reverse situation in the adult 
myocyte in rats. Recently, Schoutsen and de Jong (1987)
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demonstrated an age-dependent increase in xanthine oxidoreductase 
(xanthine oxidase plus xanthine dehydrogenase) activity in cultured 
rat myocytes. The authors did not find any variation in the 
oxidase:dehydrogenase ratio with age. Whilst these findings 
conflict with those presented here, it should be noted that the 
assay system used by Schoutsen and de Jong was both rigorous and 
time-consuming, and may not reflect the true enzyme activities of 
the cells studied. However, it must be said that the high 
dehydrogenase:oxidase ratio observed in neonatal myocytes in the 
present study was not conmon to all of the neonatal cells used.
This was true for both cardiac fibroblasts (derived from the same 
animals as the neonatal myocytes) and endothelial cells (derived 
from human umbilical vein) although the latter, of course, is of a 
different species origin.
It could be argued that the vascular location of xanthine 
oxidase-derived free radicals, indicated by the present study, 
leads to the formation of ion gradients. The studies described in 
chapter 3 demonstrated increased 86Rb+ (potassium) efflux upon 
reperfusion of isolated rat hearts which were reproduced by the 
administration of xanthine oxidase both in the presence and absence 
of xanthine. It is possible that endogenous xanthine oxidase 
induces 86Rb+ efflux via free radical generation and that the 
resultant ionic heterogeneity is arrhythmogenic. Tvro arguments 
tend to refute this proposal however. Firstly, the xanthine oxidase 
inhibitor oxypurinol, which was effective at inhibiting the enzyme 
in the cell experiments, was without effect on 86Rb+ efflux in 
isolated heart preparations. Secondly, Schoutsen and de Jong (1987)
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have shown that rabbit hearts exhibit nominal xanthine oxidase 
activity but are still vulnerable to reperfusion arrhythmias. 
Therefore, in the absence of further supportive data, it is 
inpossible to conclude a role for xanthine oxidase in mechanisms of 
reperfusion arrhythmogenesis. An investigation of the action of 
xanthine oxidase-derived free radicals on 86Rb+ fluxes in 
cardiovascular cells from various animal species including the 
rabbit may help to resolve this anomoly.
The presence of xanthine oxidase in human cardiovascular cells has 
yet to be demonstrated. The applicability of data arrived at using 
animal cells (in this case, predominantly from the rat heart) to 
the human situation cannot therefore be assumed. There is an 
obvious requirement for the application of the methods used here to 
human cells derived from adult donors. Such studies would clarify 
further the role of xanthine oxidase and xanthine dehydrogenase in 




The results presented in chapter 3 confirmed the observations of 
others (Woodward and Zakaria, 1985; Bernier et al, 1986) that 
reperfusion of regionally ischaemic isolated rat hearts evokes 
life-threatening ventricular arrhythmias. The above authors also 
showed known anti-free radical agents to be antiarrhythmic, whereas 
in the present study, the only anti-free radical drug that 
exhibited similar properties was glutathione (chapter 4). The link 
between free radicals and arrhythmias relies mainly upon 
circumstantial evidence, a reflection of the difficulties involved 
in measuring short-lived chemical species such as C>2 -~ and QH-. An 
understanding of the modes of action of radical scavengers with 
their antiarrhythmic effects is still lacking and the results of 
this study highlight the need to carefully examine other seemingly 
untoward actions of the compounds studied. For example, glutathione 
is a powerful coronary dilator (chapters 4 and 5) and its 
antiarrhythmic actions may therefore be more closely related to a 
coronary steal mechanism than to protection against free radicals. 
However, by comparing the antiarrhythmic and dilator properties of 
glutathione with those of other sulphydryl compounds 
(d-penicillamine and dithiothreitol) and vasodilator drugs (sodium 
nitroprusside and hydralazine), it becomes apparent that dilation 
is not the predominant antiarrhythmic mechanism of glutathione 
(chapter 5 and table 7.1). Similarly, the effects of 
desferrioxamine and hypoxia on the incidence of reperfusion 
arrhythmias were negligible despite accompanying dilator responses 
(chapter 4 and table 7.1), and while these results tend to negate 
the importance of oxygen radicals to reperfusion arrhythmias, they 
serve to highlight further the non-dilator-mediated antiarrhythmic
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action of glutathione.
Antiarrhythmic drugs must ultimately preserve the ionic homeostasis 
of the heart. By measuring the efflux of potassium using 86Rb+, 
reperfusion-induced arrhythmias were shown to be accompanied by a 
substantial loss of this ion. Initially, this effect was thought to 
be of potential importance to the mechanisms of the observed 
arrhythmias, since it appeared not to involve the passive washout 
of accumulated ions from the ischaemic region (chapter 3). However, 
table 7.1 clearly shows that a reduction of 86Rb+ efflux is not 
always associated with protection against arrhythmias but is more 
closely related to the magnitude of the dilation induced by the 
drug in question. Even so, this relationship is not exclusive to 
all compounds studied, the exceptions being desferrioxamine and 
oxypurinol. Indeed, the concentration-dependent dilator action of 
glutathione was not accompanied by a concentration-dependent 
reduction of 86Rb+ efflux; there appeared to be a threshold of 
dilation above which the outward movement of 86Rb+ was reduced. 
Whilst speculative explanations for these effects can be presented 
(the possible role of thiol-disulphide interactions, for example; 
see chapter 5), no definitive conclusions can yet be drawn. Changes 
in the efflux of an ion in any given area of tissue do not 
necessarily reflect the uptake kinetics of that ion. Until both are 
known, ionic heterogeneity between areas of tissue cannot be 
assumed. Similarly, the relative contributions of vascular and 
cardiac tissue to 86Rb+ efflux are unknown. A continuation of this 
study must resolve these ambiguities since, until this is done, it 
is impossible to conclude the existence (or non-existence) of a
relationship between arrhythmogenesis and 86Rb+ efflux from the 
present study.
The origin of reperfusion-induced arrhythmias is almost certainly 
multi-factorial. With accumulating evidence of the production of 
free radicals upon reperfusion, it is reasonable to suggest that 
these reactive species, with their potential to disrupt membrane 
integrity, are one such factor. Whether oxygen free radicals are 
the cause and/or initiators of arrhythmias remains to be seen. The 
data presented in chapter 4 suggests they are not of prime 
importance, since by removing the main substrate (oxygen) and 
catalysts (Fe2+ and Fe3 + ) for their production by inducing hypoxia 
or perfusing with desferrioxamine respectively, the incidence of 
arrhythmias remained at or near the control values. However, the 
experimental generation of oxygen radicals (with xanthine/xanthine 
oxidase) increased 86Rb+ efflux in non-ligated hearts by a similar 
magnitude to that observed following reperfusion. The absence*of 
arrhythmias in these experiments points to a dissociation between 
86Rb+ loss and arrhythmogenesis, although an heterogeneic rather 
than global generation of radicals (and hence elevation of 86Rb+ 
efflux) may be a prerequisite for the development of arrhythmias 
(chapter 3).
The allopurinol study (chapter 4) reaffirmed the need to assess the 
precise antiarrhythmic mechanisms of anti-free radical drugs. In 
the isolated rat heart, the xanthine oxidase inhibitor allopurinol 
exhibited substantial antiarrhythmic properties. The active 
metabolite of allopurinol, oxypurinol, was without effect on the
incidence of arrhythmias, indicating that allopurinol protects 
against rhythm disturbances by mechanisms which are unrelated to 
inhibition of xanthine oxidase. Recently (Das et al, 1987), a 
direct radical scavenging mechanism has been postulated for 
allopurinol and oxypurinol, both of which demonstrated 
antiarrhythmic properties. A role for endogenous xanthine oxidase 
as a source of arrhythmogenic free radicals is also unlikely, owing 
to the fact that animal species which possess very little enzyme 
(e.g. the rabbit) are still vulnerable to reperfusion arrhythmias. 
In the rat, however, the vascular location of xanthine oxidase 
(chapter 6) may be of importance in the pathogenesis of 
microvascular disorders which would tend to exacerbate the effects 
of ischaemia.
One question that appears to be of crucial importance to this whole 
area of study remains to be answered adequately. Do free radicals 
or radical generating systems induce changes in action potential 
characteristics of arrhythmogenic proportions? Surprisingly, only 
one recent study (Barrington et al, 1985) has attempted to answer 
this. The results demonstrated that an iron-based radical 
generating system evoked severe electrophysiological abnormalities 
upon reoxygenation of cultured myocytes. Future studies, using 
multiple electrode techniques in whole hearts under conditions of 
ischaemia/reperfusion, should help to elucidate the temporal and 
spatial electrophysiological responses to free radicals in the way 
that the effects of ischaemia were investigated by Pogwizd and Corr
(1987).
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The problems raised by the current study, together with suggestions 
for extension of the vrark, are cited within the appropriate chapter 
discussions. The tactic of screening anti-free radical agents for 
antiarrhythmic properties has provided circumstantial evidence for 
and against an involvement of oxygen radicals in 
reperfusion-induced arrhythmogenesis. Now may be a prudent time to 
begin to characterise, in detail, each individual drug, to examine 
its effect on cardiac electrophysiology and function and to 
establish the relevance of its anti-free radical role in its 







GLUTATHIONE 10-5M * 0 **
10-4M ***** 0 ****
10-3M *** ***** *****
PSH 10“ 4M 0 ***** *****
10-3M 0 ***** ****
DTT 10-3M 0 * ***
NITRO 10-8M 0 **** ***
10-7M 0 **** ****
HYDRALAZINE 10-4M **** ***** *****
DESF 10- 4M o • 0 ****
10-3M 0 0 **
OXYPURINOL 10-6M 0 0 ***
6-OHDA 60mg/kg * **** -
ANOXCAL 0 0 *****
ANOXREP 0 >control ***
ALLOPURINOL **** 0 -
Table 7.1:
Summary of the effects of drugs used in the study in terms of their 
antiarrhythmic properties, their ability to reduce the reperfusion-induced 
elevation of 86Rb+ efflux and their dilator actions.
Antiarrhythmic properties were assessed as the extent by which the 
incidences of VT and VF were reduced, and the degree by which the onset was 
delayed and the duration reduced for each type of arrhythmia.
Symbols denote the speculative scores for each parameter;
0 no effect
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APPENDIX
PROGRAMME FOR CALCULATION OF 86Rb+ EFFLUX RATE COEFFICIENTS
The following computer programme was used to calculate 86Rb+ efflux 
rate coefficients (erc's) with data obtained from liquid 
scintillation counting of perfusate and tissue samples. The 
programme was modified from that of Dr.M.Coldwell (Beechams 
Pharmaceuticals pic., Harlow, Essex) and was written for use on the 
BBC Master Series microcomputer.
The author is extremely grateful to Dr.Coldwell, and to
Drs.Christie and Mitchell (School of Pharmacy and Pharmacology,
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INPUT "NUMBER OF EFFLUX TUBES" E 
DIM A(E) /B(E) ,D(E) ,L(E) ,M(E) ,P(E) ,R(E)
INPUT "START TIME (MINS)" T 
*FX229,1
PRINT "ENTER EFFLUX COUNTS"
PRINT"AND COLLECTION PERIOD "





REM INCORRECT VALUE TRAP 
CLS
INPUT "ARE THE VALUES CORRECT? (Y/N) " YES$
IF YES$= "Y" THEN 490 
CLS
INPUT "WHICH SAMPLE NUMBER IS WRONG? "WRONGSAMP 
INPUT "WHAT IS THE CORRECT VALUE? " RIGHTVAL 
A( WRONGSAMP) =RIGHTVAL 
CLS
FOR N=1 TO E 
PRINT N,A(N)
IF N=20 REPEAT :PRINT"PRESS SPACE BAR TO CONTINUE": UNTIL GET=32:CLS 
NEXT N
INPUT "NOW ARE THE VALUES CORRECT? (Y/N) "YES2$
4
470 IF YES2$="Y" THEN 490 
480 GOTO 370 
490 CLS




540 INPUT "TISSUE COUNTS " C 
550 PRINT















710 PRINT" EFFLUX CUMUL. ";" TOTAL ";" ere "
720 PRINT" COUNTS";" TOTALS";" COUNTS ";"(/min) "
730 PRINT" (cpm) ";" (cpm) ";" (cpm) "
740 FOR N=1 TO E









840 PRINT: PRINT: PRINT: PRINT
850 INPUT "DO YOU WANT THE EFFLUX CURVE PLOTTED (ON THE SCREEN) ?(Y/N)"YES3$ 
860 IF YES3$="Y" THEN 940 
870 PRINT :@%=10:VDU3
880 PRINT"DO YOU HAVE FURTHER DATA?(Y/N)"
890 INPUT A$










990 MOVE 100,100:DRAW XLENGTH,100 
1000 MOVE 100,100:DRAW 100,940 
1010 FOR Y=1 TO 4
1020 MOVE 100,Y*210+100:DRAW 116,Y*210+100
1030 NEXT Y
1040 FOR N=1 TO E














1180 Z=R(E) DIV 10 






1240 PLOT 4,425,32: PRINT"TIME (min)11 
1250 VDU4
1260 PRINT"PRINT GRAPH ";:INPUT GRAPH$
1270 PRINT STRING$ (14," ")
1280 PRINT"erc : PER TIME PERIOD"
1290
1300 IF GRAFH$="Y" OR GRAPH$="y" PROCSDUMP ELSE GOTO 1330 
1310 PRINT"PRESS SPACE BAR TO CONTINUE"




1360 MDDE7:G0TQ 880 
1370 DEF PROCSDUMP 
1380 *SDUMP 
1390 ENDPROC
